’Apo' Aporosa, S. 2015. “The New Kava User: Diasporic Identity Formation in Reverse.” New Zealand Sociology 30 (4): 58–77.
(Apo) Aporosa, S., and Matt Tomlinson. 2014. “Kava Hangover and Gold-Standard Science.” Anthropologica 56 (1): 163–75. https://doi.org/10.1353/ant.2014.0014.
Abdel Jaleel, Gehad A., Dalia O. Saleh, and Sally A. El-Awdan. 2013. “Antihyperglycaemic Effect of Kava Kava (piper Methysticum) in Streptozotocin- Induced Diabetic Rats.” Der Pharmacia Lettre 5 (5): 104–10.
Abu, Nadiah, M. Nadeem Akhtar, Swee Keong Yeap, Kian Lam Lim, Wan Yong Ho, Aimi Jamil Zulfadli, Abdul Rahman Omar, Mohd Roslan Sulaiman, Mohd Puad Abdullah, and Noorjahan Banu Alitheen. 2014. “Flavokawain A Induces Apoptosis in MCF-7 and MDA-MB231 and Inhibits the Metastatic Process in Vitro.” PloS One 9 (10): e105244. https://doi.org/10.1371/journal.pone.0105244.
Abu, Nadiah, Wan Yong Ho, Swee Keong Yeap, M. Nadeem Akhtar, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2013. “The Flavokawains: Uprising Medicinal Chalcones.” Cancer Cell International 13 (1): 102. https://doi.org/10.1186/1475-2867-13-102.
Abu, Nadiah, Nurul Elyani Mohamed, Swee Keong Yeap, Kian Lam Lim, M. Nadeem Akhtar, Aimi Jamil Zulfadli, Beh Boon Kee, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2015. “In Vivo Antitumor and Antimetastatic Effects of Flavokawain B in 4T1 Breast Cancer Cell-Challenged Mice.” Drug Design, Development and Therapy 9 (March): 1401–17. https://doi.org/10.2147/DDDT.S67976.
Abu, Nadiah, Nurul Elyani Mohameda, Nirosha Tangarajoo, Swee Keong Yeap, M. Nadeem Akhtar, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2015. “In Vitro Toxicity and in Vivo Immunomodulatory Effects of Flavokawain A and Flavokawain B in Balb/C Mice.” Natural Product Communications 10 (7): 1199–1202. https://doi.org/10.1177/1934578X1501000716.
Ambrose, W. 1991. “Manus, Mortars and the Kava Concoction.” https://www.semanticscholar.org/paper/097e6b89e9b9b7cd01a76f4f8bc07e300fbca9ca.
Amdidouche-Hussain’I, Didja, and Joel Levesque. 1997. “Selection of Kavalactones by Complexation of Kava Extract with C Yclodextrins.” Drug Development and Industrial Pharmacy 23 (12): 1223–26. https://doi.org/10.3109/03639049709146161.
Anke, J., S. Fu, and I. Ramzan. 2006. “Kavalactones Fail to Inhibit Alcohol Dehydrogenase in Vitro.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 13 (3): 192–95. https://doi.org/10.1016/j.phymed.2004.07.005.
Anke, Jennifer, and Iqbal Ramzan. 2004a. “Pharmacokinetic and Pharmacodynamic Drug Interactions with Kava (Piper Methysticum Forst. F.).” Journal of Ethnopharmacology 93 (2-3): 153–60. https://doi.org/10.1016/j.jep.2004.04.009.
Anke, Jennifer, and Iqqbal Ramzan. 2004b. “Kava Hepatotoxicity: Are We Any Closer to the Truth?” Planta Medica 70: 193–96. https://doi.org/10.1055/s-2004-815533.
Apo Aporosa, S. 2011. “Apososa S. ‘Apo’ - 2011 - Is Kava Alcohol The Myths and the Facts.pdf.” Pacific Health Dialog 17 (1): 157–64. https://pubmed.ncbi.nlm.nih.gov/23008981/.
Apo’Aporosa, S. 2015. “Yaqona (kava) as a Symbol of Cultural Identity.” S. ‘. Aporosa.
Aporosa, A. S. 2019. “Kava, the Devil, and the Snake: Pentecostal Iconoclasm in Contemporary Fiji.” University of Auckland.
Aporosa, Apo. 2019. “Australia’s Discussion of Kava Imports Reflects Lack of Cultural Understanding.” The Conversation, June 9, 2019. http://theconversation.com/australi...eflects-lack-of-cultural-understanding-115662.
Aporosa, Apo S., Martin Atkins, and Richard Brunton. 2020. “Kava Drinking in Traditional Settings: Towards Understanding Effects on Cognitive Function.” Human Psychopharmacology 35 (2): e2725. https://doi.org/10.1002/hup.2725.
Aporosa, S. 2017. “Understanding Cognitive Functions Related to Driving Following Kava (Piper Methysticum) Use at Traditional Consumption Volumes.” In British Association for Psychopharmacology Conference, A84–A84. SAGE Publications. https://researchcommons.waikato.ac.nz/handle/10289/11307.
———. 2018. “Improving Road Safety and Health: Understanding Kava’s Impact on Driver Fitness.” University of Waikato. https://researchcommons.waikato.ac.nz/handle/10289/12947.
———. 2019. “Cognitive Functions Associated with Consumption of Traditional Volumes of Kava (Piper Methysticum): A Feasibility Study.” In British Association for Psychopharmacology. researchcommons.waikato.ac.nz. https://researchcommons.waikato.ac.nz/handle/10289/12780.
Aporosa, S. Apo. 2019a. “Kava and Ethno-Cultural Identity in Oceania.” In The Palgrave Handbook of Ethnicity, edited by Steven Ratuva, 1–15. Singapore: Springer Singapore. https://doi.org/10.1007/978-981-13-0242-8_134-1.
———. 2019b. “De-Mythologizing and Re-Branding of Kava as the New ‘world Drug’ of Choice.” Drug Science, Policy and Law 5 (January): 2050324519876131. https://doi.org/10.1177/2050324519876131.
Aporosa, S. Apo, Martin Atkins, and Jess N. Leov. 2021. “Decolonising Quantitative Methods within a Pacific Research Space to Explore Cognitive Effects Following Kava Use.” Journal of Interdisciplinary Research 5 (1). https://doi.org/10.26021/10642.
Aporosa, S. ’apo'. 2014. “YAQONA (KAVA) AND EDUCATION IN FIJI:INVESTIGATING ‘CULTURAL COMPLEXITIES’FROM A POST-DEVELOPMENT PERSPECTIVE.”
Aporosa, S., and Jacinta Forde. 2019. “Māori and Kava: New Drug Fashion or Re-Engagement With’kawa'?” Pacific Dynamics 3 (1): 72–85. https://researchcommons.waikato.ac.nz/handle/10289/12952.
Aporosa, S. G. 2008. Yaqona (Kava) and Education in Fiji: A Clash of Cultures? VDM Verlag.
Ashraf-Khorassani, M., L. T. Taylor, and M. Martin. 1999. “Supercritical Fluid Extraction of Kava Lactones from Kava Root and Their Separation via Supercritical Fluid Chromatography.” Chromatographia 50: 287–92. https://doi.org/10.1007/BF02490830.
Backhaul, Cord, and Josef Krieglstein. 1992. “Extract of Kava ( Piper Methysticum) and Its Methysticin Constituents Protect Brain Tissue against Ischemic Damage in Rodents.” European Journal ~>~ Pharmacoloj, % 215: 265269.
Backleh, Marlène, Perihan Ekici, Günther Leupold, and Harun Parlar. 2003. “Quantitative Elimination of Flavokavines A and B from Kava Kava (Piper Methysticum G. Forst) by Isoelectric Focused Adsorptive Bubble Separation.” Die Naturwissenschaften 90 (8): 366–69. https://doi.org/10.1007/s00114-003-0440-5.
Baker, Jonathan D. 2011. “Tradition and Toxicity: Evidential Cultures in the Kava Safety Debate.” Social Studies of Science 41 (3): 361–84. https://doi.org/10.1177/0306312710395341.
———. 2012. “Pills, Potions, Products: Kava’s Transformations in New and Nontraditional Contexts.” The Contemporary Pacific 24 (2): 233–65. https://doi.org/10.1353/cp.2012.0026.
Balick, Michael J., and Roberta Lee. 2002. “Traditional Use of Sakau (kava) in Pohnpei: Lessons for Integrative Medicine.” Alternative Therapies in Health and Medicine 8 (4): 96–98. https://www.ncbi.nlm.nih.gov/pubmed/12126179.
Balick, Michael J & Lee, Robert A. 2009. “The Sacred Root.” In Ethnobotany of Pohnpei, 165–203. University of Hawaii Press.
Barguil, Yann, Erwan Choblet, Sébastien Warter, and Mohammed Nour. 2013. “Kava Ichthyosis: A Nitric Oxide Synthase Inhibition?” Annales de Toxicologie Analytique 25 (4): 165–68. https://doi.org/10.1051/ata/2014001.
Barnes, Joanne, Linda A. Anderson, and J. D. Phillipson. 2007. “Kava - Overview.” In Herbal Medicines, 389–402. 3rd Ed. Grayslake, IL: Pharmaceutical Press.
Bauer, Rudolf, Brigitte & Kopp, and A. Nahrstedt. 2003. “Relevant Hepatotoxic Effects of Kava Still Need to Be Proven: A Statement of the Society for Medicinal Plant Research.” Planta Medica 69 (11): 971–72. https://doi.org/10.1055/s-2003-45140.
Baum, S. S., R. Hill, and H. Rommelspacher. 1998. “Effect of Kava Extract and Individual Kavapyrones on Neurotransmitter Levels in the Nucleus Accumbens of Rats.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 22 (7): 1105–20. https://doi.org/10.1016/s0278-5846(98)00062-1.
Becker, Matheus William, Emerson Matheus Silva Lourençone, Alexandre Formighieri De Mello, Aline Branco, Edison Moraes Rodrigues Filho, Celso Ronaldo Blatt, Carlos Augusto Mallmann, Maurício Schneider, Rita Catalina Aquino Caregnato, and Carine Raquel Blatt. 2019. “Liver Transplantation and the Use of KAVA: Case Report.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 56 (March): 21–26. https://doi.org/10.1016/j.phymed.2018.08.011.
Behl, Mamta, Abraham Nyska, Rajendra S. Chhabra, Gregory S. Travlos, Laurene M. Fomby, Barney R. Sparrow, Milton R. Hejtmancik, and Po C. Chan. 2011. “Liver Toxicity and Carcinogenicity in F344/N Rats and B6C3F1 Mice Exposed to Kava Kava.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49 (11): 2820–29. https://doi.org/10.1016/j.fct.2011.07.067.
Berry, Jonna, Ashley Gilbert, and Justin Grodnitzky. 2019. “Cases of Kava Impairment in Iowa Drivers.” Journal of Forensic Sciences 64 (6): 1943–49. https://doi.org/10.1111/1556-4029.14130.
BfArM. 2002. “Kava Removal.” http://lrd.spc.int/ahp-publications/doc_download/578-gr-cis-bfarm-kava-removal.
Bian, Tengfei, Pedro Corral, Yuzhi Wang, Jordy Botello, Rick Kingston, Tyler Daniels, Ramzi G. Salloum, et al. 2020. “Kava as a Clinical Nutrient: Promises and Challenges.” Nutrients 12 (10). https://doi.org/10.3390/nu12103044.
Bilia, Anna Rita, Sandra Gallon, and Franco F. Vincieri. 2002. “Kava-Kava and Anxiety: Growing Knowledge about the Efficacy and Safety.” Life Sciences 70 (22): 2581–97. https://doi.org/10.1016/s0024-3205(02)01555-2.
Bilia, Anna Rita, Luca Scalise, Maria Camilla Bergonzi, and Franco F. Vincieri. 2004. “Analysis of Kavalactones from Piper Methysticum (kava-Kava).” Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 812 (1-2): 203–14. https://doi.org/10.1016/j.jchromb.2004.07.038.
Bird, Gail. 2016. “Import Restrictions: Kava and Khat.” The Office of Drug Control. December 7, 2016. https://www.odc.gov.au/import-restrictions-kava-and-khat.
Boerner, R. J. 2001. “Kava Kava in the Treatment of Generalized Anxiety Disorder, Simple Phobia and Specific Social Phobia.” Phytotherapy Research: PTR 15 (7): 646–47. https://doi.org/10.1002/ptr.1006.
Boerner, R. J., H. Sommer, W. Berger, U. Kuhn, U. Schmidt, and M. Mannel. 2003. “Kava-Kava Extract LI 150 Is as Effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-Week Randomized, Double-Blind Multi-Centre Clinical Trial in 129 out-Patients.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 10 Suppl 4: 38–49. https://doi.org/10.1078/1433-187x-00309.
Boerner, Reinhard J., and Stephan Klement. 2004. “Attenuation of Neuroleptic-Induced Extrapyramidal Side Effects by Kava Special Extract WS 1490.” Wiener Medizinische Wochenschrift 154 (21-22): 508–10. https://doi.org/10.1007/s10354-004-0115-7.
Boonen, G., B. Ferger, K. Kuschinsky, and H. Häberleinl. 1998. “In Vivo Effects of the Kavapyrones (+)-Dihydromethysticin And(±)-Kavain on Dopamine, 3,4-Dihydroxyphenylacetic Acid, Serotonin and 5-Hydroxyindoleacetic Acid Levels in Striatal and Cortical Brain Regions.” Planta Medica 64: 507–10.
Boonen, Georg, and Hanns Hberlein. 1998. “Influence of Genuine Kavapyrone Enantiomerson the GABAA Binding Site.” Planta Medica 64: 504–6.
Botello, Jordy F., Pedro Corral, Tengfei Bian, and Chengguo Xing. 2020. “Kava and Its Kavalactones Inhibit Norepinephrine-Induced Intracellular Calcium Influx in Lung Cancer Cells.” Planta Med 86 (1): 26–31. https://doi.org/10.1055/a-1035-5183.
Brown, Amy C., Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J. Craig, Klaus Dragull, Arieh M. Levine, and Jonathan D. Baker. 2007. “Traditional Kava Beverage Consumption and Liver Function Tests in a Predominantly Tongan Population in Hawaii.” Clinical Toxicology 45 (5): 549–56. https://doi.org/10.1080/15563650701365875.
Butt, Julia. 2019. Kava Usage in Aboriginal and Pacific Islander Communities in Australia. National Drug Research Institute.
Cairney, Sheree, Alan R. Clough, Paul Maruff, Alex Collie, Bart J. Currie, and Jon Currie. 2003. “Saccade and Cognitive Function in Chronic Kava Users.” Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28 (2): 389–96. https://doi.org/10.1038/sj.npp.1300052.
Cairney, Sheree, Paul Maruff, and Alan R. Clough. 2002. “The Neurobehavioural Effects of Kava.” The Australian and New Zealand Journal of Psychiatry 36 (5): 657–62. https://doi.org/10.1046/j.1440-1614.2002.01027.x.
Capasso, A., and L. Sorrentino. 2005. “Pharmacological Studies on the Sedative and Hypnotic Effect of Kava Kava and Passiflora Extracts Combination.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 12 (1-2): 39–45. https://doi.org/10.1016/j.phymed.2004.03.006.
Catchpole, O. J., N. B. Perry, B. M. T. da Silva, J. B. Grey, and B. M. Smallfield. 2002. “Supercritical Extraction of Herbs I: Saw Palmetto, St John’s Wort, Kava Root, and Echinacea.” The Journal of Supercritical Fluids 22 (2): 129–38. https://doi.org/10.1016/S0896-8446(01)00110-3.
Cawte, John. 1986. “Parameters of Kava Used as a Challenge to Alcohol.” The Australian and New Zealand Journal of Psychiatry 20 (1): 70–76. https://doi.org/10.3109/00048678609158867.
Celentano, Antonio, Andrew Tran, Claire Testa, Krishen Thayanantha, William Tan-Orders, Stephanie Tan, Mitali Syamal, Michael J. McCullough, and Tami Yap. 2019. “The Protective Effects of Kava (Piper Methysticum) Constituents in Cancers: A Systematic Review.” Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 48 (7): 510–29. https://doi.org/10.1111/jop.12900.
Celentano, Antonio, Callisthenis Yiannis, Rita Paolini, Pangzhen Zhang, Camile S. Farah, Nicola Cirillo, Tami Yap, and Michael McCullough. 2020. “Kava Constituents Exert Selective Anticancer Effects in Oral Squamous Cell Carcinoma Cells in Vitro.” Scientific Reports 10 (1): 1–11. https://doi.org/10.1038/s41598-020-73058-4.
Chambers, Megan I., Amy M. Osborne, and Rabi A. Musah. 2019. “Rapid Detection and Validated Quantification of Psychoactive Compounds in Complex Plant Matrices by Direct Analysis in Real Time-High Resolution Mass Spectrometry - Application to ‘Kava’ Psychoactive Pepper Products.” Rapid Communications in Mass Spectrometry: RCM 33 (24): 1915–25. https://doi.org/10.1002/rcm.8532.
Chaurasiya, Narayan D., Francisco León, Yuanqing Ding, Isabel Gómez-Betancur, Dora Benjumea, Larry A. Walker, Stephen J. Cutler, and Babu L. Tekwani. 2017. “Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia Alpinia, with Human Monoamine Oxidase-A and Oxidase-B.” Evidence-Based Complementary and Alternative Medicine: eCAM 2017 (August): 4018724. https://doi.org/10.1155/2017/4018724.
Chou, Tsui-Wei, Jia-Hua Feng, Chi-Chang Huang, Ya-Wen Cheng, Shih-Chang Chien, Sheng-Yang Wang, and Lie-Fen Shyur. 2013. “A Plant Kavalactone Desmethoxyyangonin Prevents Inflammation and Fulminant Hepatitis in Mice.” PloS One 8 (10): e77626. https://doi.org/10.1371/journal.pone.0077626.
Chua, Han Chow, Emilie T. H. Christensen, Kirsten Hoestgaard-Jensen, Leonny Y. Hartiadi, Iqbal Ramzan, Anders A. Jensen, Nathan L. Absalom, and Mary Chebib. 2016. “Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.” PloS One 11 (6): e0157700. https://doi.org/10.1371/journal.pone.0157700.
Clayton, Natasha P., Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan, and Abraham Nyska. 2007. “Immunohistochemical Analysis of Expressions of Hepatic Cytochrome P450 in F344 Rats Following Oral Treatment with Kava Extract.” Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft Fur Toxikologische Pathologie 58: 223–36. https://doi.org/10.1016/j.etp.2006.08.002.
Clouatre, Dallas L. 2004. “Kava Kava: Examining New Reports of Toxicity.” Toxicology Letters 150: 85–96. https://doi.org/10.1016/j.toxlet.2003.07.005.
Clough, A. R., S. P. Jacups, Z. Wang, C. B. Burns, R. S. Bailie, S. J. Cairney, A. Collie, T. Guyula, S. P. McDonald, and B. J. Currie. 2003. “Health Effects of Kava Use in an Eastern Arnhem Land Aboriginal Community.” Internal Medicine Journal 33 (8): 336–40. https://doi.org/10.1046/j.1444-0903.2003.00405.x.
Clough, A. R., K. Rowley, and K. O’Dea. 2004. “Kava Use, Dyslipidaemia and Biomarkers of Dietary Quality in Aboriginal People in Arnhem Land in the Northern Territory (NT), Australia.” European Journal of Clinical Nutrition 58 (7): 1090–93. https://doi.org/10.1038/sj.ejcn.1601921.
Clough, Alan. 2003. “Enough! Or Too Much. What Is ‘Excessive’ Kava Use in Arnhem Land?” Drug and Alcohol Review 22 (1): 43–51. https://doi.org/10.1080/0959523021000059820.
Clough, Alan R., Sheree Cairney, Paul Maruff, Chris B. Burns, and Bart J. Currie. 2001. “Possible Toxicity and Withdrawal Seizures in Aboriginal Kava Drinkers in Arnhem Land, (Australia).” South Pacific Journal of Psychology 13: 26–33. https://doi.org/10.1017/S025754340000033X.
Connell, John. 2007. “Towards Free Trade in the Pacific? The Genesis of the ‘Kava-Biscuit War’ between Fiji and Vanuatu.” Geographical Research 45 (1): 1–12. https://doi.org/10.1111/j.1745-5871.2007.00425.x.
Connor, K. M., J. R. Davidson, and L. E. Churchill. 2001. “Adverse-Effect Profile of Kava.” CNS Spectrums 6 (10): 848, 850–53. https://doi.org/10.1017/s109285290000167x.
Connor, K. M., and J. R. T. Davidson. 2002. “A Placebo-Controlled Study of Kava Kava in Generalized Anxiety Disorder.” International Clinical Psychopharmacology 17 (4): 185–88. https://doi.org/10.1097/00004850-200207000-00005.
Connor, Kathryn M., Victoria Payne, and Jonathan R. T. Davidson. 2006. “Kava in Generalized Anxiety Disorder: Three Placebo-Controlled Trials.” International Clinical Psychopharmacology 21 (5): 249–53. https://doi.org/10.1097/00004850-200609000-00001.
Costa, Willian Richardes, Lucas Rossi Sartori, and José C. Tavares Carvalho. 2010. “Study of In Vitro and In Vivo Extraction of Kavalactones of Pharmaceutical Form Containing Ground Plant Drug (Piper Methysticum G. Forster).” Latin American Journal of Pharmacy 29 (2): 289–92. https://www.academia.edu/download/49124391/Kavalactones_LAJP.pdf.
Côté, Cynthia S., Christine Kor, Jon Cohen, and Karine Auclair. 2004. “Composition and Biological Activity of Traditional and Commercial Kava Extracts.” Biochemical and Biophysical Research Communications 322 (1): 147–52. https://doi.org/10.1016/j.bbrc.2004.07.093.
Coulter, David, Tamayo Carmen Sotheeswaran Subramaniam, Catherine Ulbricht, and World Health Organization. 2007. “Assessment of the Risk of Hepatotoxicity with Kava Products.pdf.” World Health Organization.
Cox, Paul Alan, and Lisa O’Rourke. 1987. “Kava (Piper Methysticum, Piperaceae).” Economic Botany 41 (3): 452–54. http://www.jstor.org/stable/4254999.
D. Schmitz ,CL Zhang ,SS Chatterjee &U. Heinemann. 1995. “Effects of Methysticin on Three Different Models of Seizure like Events Studied in Rat Hippocampal and Entorhinal Cortex Slices.” Naunyn-Schmiedeberg’s Archives of Pharmacology 351: 348–55. https://doi.org/10.1007/BF00169074.
Dai, Jun-Qi, Yi-Gang Huang, and Ai-Na He. 2015. “Dihydromethysticin Kavalactone Induces Apoptosis in Osteosarcoma Cells through Modulation of PI3K/Akt Pathway, Disruption of Mitochondrial Membrane Potential and Inducing Cell Cycle Arrest.” International Journal of Clinical and Experimental Pathology 8 (5): 4356–66. https://www.ncbi.nlm.nih.gov/pubmed/26191127.
Danan, Gaby, and Rolf Teschke. 2015. “RUCAM in Drug and Herb Induced Liver Injury: The Update.” International Journal of Molecular Sciences 17 (1). https://doi.org/10.3390/ijms17010014.
Davies, L. P., C. A. Drew, P. Duffield, G. A. Johnston, and D. D. Jamieson. 1992. “Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain.” Pharmacology & Toxicology 71 (2): 120–26. https://doi.org/10.1111/j.1600-0773.1992.tb00530.x.
De Leo, V., A. la Marca, G. Morgante, D. Lanzetta, P. Florio, and F. Petraglia. 2001. “Evaluation of Combining Kava Extract with Hormone Replacement Therapy in the Treatment of Postmenopausal Anxiety.” Maturitas 39 (2): 185–88. https://doi.org/10.1016/s0378-5122(01)00197-9.
Denery, Judith R., Klaus Dragull, C. S. Tang, and Qing X. Li. 2004. “Pressurized Fluid Extraction of Carotenoids from Haematococcus Pluvialis and Dunaliella Salina and Kavalactones from Piper Methysticum.” Analytica Chimica Acta 501 (2): 175–81. https://doi.org/10.1016/j.aca.2003.09.026.
Denham, Alison, Michael McIntyre, and Julie Whitehouse. 2002. “Kava—the Unfolding Story: Report on a Work-in-Progress.” The Journal of Alternative and Complementary Medicine 8 (3): 237–63. https://doi.org/10.1089/10755530260127943.
Dentali, Steven J., Cristina Amarillas, Tyler Blythe, Paula N. Brown, Anton Bzhelyansky, Christine Fields, Holly E. Johnson, et al. 2018. “Standard Method Performance Requirements (SMPRs®) 2018.005: Determination of Kavalactones And/or Flavokavains from Kava (Piper Methysticum).” Journal of AOAC International 101 (4): 1256–60. https://doi.org/10.5740/jaoacint.smpr2018.005.
Department of Industry, Tourism and Trade. 2020. “KAVA MANAGEMENT ACT 1998.” https://legislation.nt.gov.au/Legislation/KAVA-MANAGEMENT-ACT-1998.
Dharmaratne, H. Ranjith W., N. P. Dhammika Nanayakkara, and Ikhlas A. Khan. 2002. “Kavalactones from Piper Methysticum, and Their 13C NMR Spectroscopic Analyses.” Phytochemistry 59 (4): 429–33. https://doi.org/10.1016/s0031-9422(01)00443-5.
Dietlein, G., and D. Schröder-Bernhardi. 2003. “Doctors’ Prescription Behaviour Regarding Dosage Recommendations for Preparations of Kava Extracts.” Pharmacoepidemiology and Drug Safety 12 (5): 417–21. https://doi.org/10.1002/pds.839.
Dinh, L. D., U. Simmen, K. B. Bueter, B. Bueter, K. Lundstrom, and W. Schaffner. 2001. “Interaction of Various Piper Methysticum Cultivars with CNS Receptors in Vitro.” Planta Medica 67 (4): 306–11. https://doi.org/10.1055/s-2001-14334.
DiSilvestro, Robert A., Wenyi Zhang, and David J. DiSilvestro. 2007. “Kava Feeding in Rats Does Not Cause Liver Injury nor Enhance Galactosamine-Induced Hepatitis.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 45 (7): 1293–1300. https://doi.org/10.1016/j.fct.2007.01.015.
Einbond, L. S., A. Negrin, D. M. Kulakowski, H-A Wu, V. Antonetti, F. Jalees, W. Law, et al. 2017. “Traditional Preparations of Kava (Piper Methysticum) Inhibit the Growth of Human Colon Cancer Cells in Vitro.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 24 (January): 1–13. https://doi.org/10.1016/j.phymed.2016.11.002.
Ernst, E. 2007. “A Re-Evaluation of Kava (Piper Methysticum).” British Journal of Clinical Pharmacology 64 (4): 415–17. https://doi.org/10.1111/j.1365-2125.2007.02932.x.
Ernst, Edzard. 2002. “Second Thoughts about Kava.” The American Journal of Medicine 113 (4): 347–48. https://doi.org/10.1016/S0002-9343(02)01204-4.
Fehoko, E. 2013. “From Kava to Coffee: Tongan Young People in Auckland.” Mana Ngākau: Community Compassion Māori and. https://www.academia.edu/download/33781543/From_Kava_to_Coffee_Tongan_Young_People_in_Auckland.pdf.
Fehoko, E., I. Hafoka, and A. Tecun. 2021. “Holding Tightly onto Land and People During a Pandemic: Kava Pedagogies and Tertiary Learning Relationships in Vahaope.” Researchgate.net. https://www.researchgate.net/profil...ertiary-Learning-Relationships-in-Vahaope.pdf.
Feltenstein, Matt W., L. Corinne Lambdin, M. Ganzera, H. Ranjith, W. Dharmaratne, N. P. Dhammika Nanayakkara, Ikhlas A. Khan, and Kenneth J. Sufka. 2003. “Anxiolytic Properties of Piper Methysticum Extract Samples and Fractions in the Chick Social-Separation-Stress Procedure.” Phytotherapy Research: PTR 17 (3): 210–16. https://doi.org/10.1002/ptr.1107.
Ferreira, Juliana Veloso, Isabella Campolina Pierotte, Gerson Antônio Pianetti, and Isabela Costa César. 2020. “Simultaneous Quantitation of Kavalactones in Kava Dry Extracts: Comparison of Multi-Standards and Single Standard Validation Approaches.” Phytochemical Analysis: PCA, December. https://doi.org/10.1002/pca.3019.
Flynn, Nicole. 2016. “Comparison of the Anxiolytic Effects of Diazepam and Kava on Behaviour in Rats.” Master of Arts, University of Canterbury. http://ir.canterbury.ac.nz/handle/10092/12806.
Foo, H., and J. Lemon. 1997. “Acute Effects of Kava, Alone or in Combination with Alcohol, on Subjective Measures of Impairment and Intoxication and on Cognitive Performance.” Drug and Alcohol Review 16 (2): 147–55. https://doi.org/10.1080/09595239700186441.
Food and Agriculture Organization of the United Nations, and WHO. 2016. “Kava: A Review of the Safety of Traditional and Recreational Beverage Consumption.”
Food Standards Australia New Zealand. 2004. “KAVA A Human Health Risk Assessment.” 30.
Fragoulis, Athanassios, Stephanie Siegl, Markus Fendt, Sandra Jansen, Ulf Soppa, Lars-Ove Brandenburg, Thomas Pufe, Joachim Weis, and Christoph Jan Wruck. 2017. “Oral Administration of Methysticin Improves Cognitive Deficits in a Mouse Model of Alzheimer’s Disease.” Redox Biology 12 (August): 843–53. https://doi.org/10.1016/j.redox.2017.04.024.
Fu, Dong, and Iqbal Ramzan. 2015. “Use of Kava as a Phytotherapeutic Agent and Kava‐Related Hepatotoxicity.” Phytotherapies, 312–29. https://doi.org/10.1002/9781119006039.ch13.
Fu, Peter P., Qingsu Xia, Lei Guo, Hongtao Yu, and Po-Chuen Chan. 2008. “Toxicity of Kava Kava.” Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews 26 (1): 89–112. https://doi.org/10.1080/10590500801907407.
Fu, Shuang, Anthony Rowe, and Iqbal Ramzan. 2012. “Kavalactone Metabolism in the Isolated Perfused Rat Liver.” Phytotherapy Research: PTR 26 (12): 1813–16. https://doi.org/10.1002/ptr.4656.
Garner, L. F., and J. D. Klinger. 1985. “Some Visual Effects Caused by the Beverage Kava.” Ethnopharmacol. 13 (3): 307–11. https://doi.org/10.1016/0378-8741(85)90076-5.
Gastpar, M., and H. D. Klimm. 2003. “Treatment of Anxiety, Tension and Restlessness States with Kava Special Extract WS 1490 in General Practice: A Randomized Placebo-Controlled Double-Blind Multicenter Trial.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 10 (8): 631–39. https://doi.org/10.1078/0944-7113-00369.
Geier, F. P., and T. Konstantinowicz. 2004. “Kava Treatment in Patients with Anxiety.” Phytotherapy Research: PTR 18 (4): 297–300. https://doi.org/10.1002/ptr.1422.
Gendle, M. H., A. K. Stroman, and D. P. Mullin. 2011. “Effect of an Acute Dose of Crude Kava Root Extract on Problem Solving in Healthy Young Adults.” Australian Journal of Medical Herbalism 23 (4): 160–63. https://search.informit.org/doi/abs/10.3316/informit.858304482995950.
Gerren, Andrew. 2017. “Effects of Varietal Diversity on Knowledge of Kava (Piper Methysticum) in the Pacific.” University of Hawaii at Manoa, May. http://128.171.57.22/handle/10125/56539.
Gleitz, J., A. Beile, P. Wilkens, A. Ameri, and Peters T. 1997. “Gleitz1’ et Al. - 1997 - Antithrombotic Action of the Kava Pyrone ()-Kavain Prepared from Piper Methysticum on Human Platelets.” Planta Medica 63 (1): 27–30. https://doi.org/10.1055/s-2006-957597.
Gow, Paul J., Nathan J. Connelly, Richard L. Hill, Peter Crowley, and Peter W. Angus. 2003. “Fatal Fulminant Hepatic Failure Induced by a Natural Therapy Containing Kava.” The Medical Journal of Australia 178 (9): 442–43. https://doi.org/10.5694/j.1326-5377.2003.tb05286.x.
Grace, Robert F. 2003. “Kava Drinking in Vanuatu--a Hospital Based Survey.” Pacific Health Dialog 10 (2): 41–44. https://www.ncbi.nlm.nih.gov/pubmed/18181414.
Gregory, R. J., J. E. Gregory, and J. G. Peck. 1981. “Kava and Prohibition in Tanna, Vanuatu.” British Journal of Addiction 76 (3): 299–313. https://doi.org/10.1111/j.1360-0443.1981.tb00236.x.
Groth-Marnat, G., S. Leslie, and M. Renneker. 1996. “Tobacco Control in a Traditional Fijian Village: Indigenous Methods of Smoking Cessation and Relapse Prevention.” Social Science & Medicine 43 (4): 473–77. https://doi.org/10.1016/0277-9536(95)00425-4.
Grunze, Heinz, Jens Langosch, Karin Schirrmacher, Dieter Bingmann, Jörg von Wegerer, and Jörg Walden. 2001. “Kava Pyrones Exert Effects on Neuronal Transmission and Transmembraneous Cation Currents Similar to Established Mood Stabilizers - a Review.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 25 (8): 1555–70. https://doi.org/10.1016/S0278-5846(01)00208-1.
Guo, Lei, Qiang Shi, Stacey Dial, Qingsu Xia, Nan Mei, Quan-Zhen Li, Po-Chuen Chan, and Peter Fu. 2010. “Gene Expression Profiling in Male B6C3F1 Mouse Livers Exposed to Kava Identifies--Changes in Drug Metabolizing Genes and Potential Mechanisms Linked to Kava Toxicity.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48 (2): 686–96. https://doi.org/10.1016/j.fct.2009.11.050.
Gurgel Andrade Pedrosa, Elaine Cristina, Ana Paula Carvalho Bezerra, Ianara Mendonça da Costa, Francisco Irochima Pinheiro, and Fausto Pierdoná Guzen. 2020. “Neuroprotective Profile of Piper Methysticum (Kava Kava) and Its Effects on the Central Nervous System: A Systematic Review.” Journal of Pharmacological Chemistry and Biological Sciences 2 (1): 55–84. https://doi.org/10.36619/jpcbs.2020.2.56.80.
Gurley, Bill J., Ashley Swain, Martha A. Hubbard, D. Keith Williams, Gary Barone, Faith Hartsfield, Yudong Tong, Danielle J. Carrier, Shreekar Cheboyina, and Sunil K. Battu. 2008. “Clinical Assessment of CYP2D6-Mediated Herb-Drug Interactions in Humans: Effects of Milk Thistle, Black Cohosh, Goldenseal, Kava Kava, St. John’s Wort, and Echinacea.” Molecular Nutrition & Food Research 52 (7): 755–63. https://doi.org/10.1002/mnfr.200600300.
H.B. NO. 2494 - ‘Awa; Official State Beverage of Hawaii. 2018. https://www.capitol.hawaii.gov/session2018/bills/HB2494_.HTM.
Hannam, Sarah, Michael Murray, Lucia Romani, Meciusela Tuicakau, and Margot J Whitfeld. 2014. “Kava Dermopathy in Fiji: An Acquired Ichthyosis?” International Journal of Dermatology 53 (12): 1490–94. https://doi.org/10.1111/ijd.12546.
Hegazy, Nada Hany, Hans-Georg Breitinger, and Ulrike Breitinger. 2019. “Kavalactones from Kava (Piper Methysticum) Root Extract as Modulators of Recombinant Human Glycine Receptors.” Biological Chemistry 400 (9): 1205–15. https://doi.org/10.1515/hsz-2019-0112.
Heinze, H. J. 1994. “Pharmacopsychological EfTects ofOxazepam and Kava-Extract in a Visual Search Paradigm Assessed with Event-Related Potentials.” Phannacopsychiat. 27: 224–30.
Hocart, C. H., B. Fankhauser, and D. W. Buckle. 1993. “Chemical Archaeology of Kava, a Potent Brew.” Rapid Communications in Mass Spectrometry: RCM 7 (3): 219–24. https://doi.org/10.1002/rcm.1290070311.
Hong, Nguyen Huu, Tran Dang Xuan, Tsuzuki Eiji, Mitsuhiro Matsuo, and Ogushi Yuichi. 2002. “Evaluation of the Allelopathic Potential of Kava (Piper Methysticum L.) for Weed Control in Rice.” Weed Biology and Management 2 (3): 143–47. https://doi.org/10.1046/j.1445-6664.2002.00062.x.
Hoover, Jason M., Alan D. Kaye, Ikhlass N. Ibrahim, Aaron M. Fields, and Todd A. Richards. 2006. “Analysis of Responses to Kava Kava in the Feline Pulmonary Vascular Bed.” Journal of Medicinal Food 9 (1): 62–71. https://doi.org/10.1089/jmf.2006.9.62.
Hussein, Anan. 2015. “A Closer Look at the Risks vs. Benefits of Kava (Piper Methysticum).” Journal of Student Research 4 (2): 69–72. https://doi.org/10.47611/jsr.v4i2.245.
IARC. 2013. “Kava.” In Some Drugs and Herbal Products, 117–40.
“Increasing Consumer Access to Kava.” n.d. Accessed April 19, 2021. https://www.odc.gov.au/publications/increasing-consumer-access-kava.
Jager, L. S. de, G. A. Perfetti, and G. W. Diachenko. 2004. “LC-UV and LC-MS Analysis of Food and Drink Products Containing Kava.” Food Additives and Contaminants 21 (10): 921–34. https://doi.org/10.1080/02652030400010454.
Jaiswal, Yogini S., Aaron M. Yerke, M. Caleb Bagley, Mans Ekelof, Daniel Weber, Daniel Haddad, Anthony Fodor, David C. Muddiman, and Leonard L. Williams. 2020. “3D Imaging and Metabolomic Profiling Reveal Higher Neuroactive Kavalactone Contents in Lateral Roots and Crown Root Peels of Piper Methysticum (kava).” GigaScience 9 (9). https://doi.org/10.5524/100784.
Jaiswal, Yogini, Mohd Farooq Shaikh, Ilya Wang, Yanning Yong, Vanessa Lin Lin Lee, and Leonard Williams. 2020. “Evaluation of Anti-Convulsive Properties of Aqueous Kava Extract on Zebrafish Using the PTZ-Induced Seizure Model.” Brain Sciences 10 (8). https://doi.org/10.3390/brainsci10080541.
Jandial, Danielle D., Lauren S. Krill, Lixia Chen, Chunli Wu, Yu Ke, Jun Xie, Bang H. Hoang, and Xiaolin Zi. 2017. “Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.” Molecules 22 (3). https://doi.org/10.3390/molecules22030462.
Jayararnan, T. K. 2004. “COPING WITH VULNERABILITY BY BUILDING ECONOMIC RESILIENCE: THE CASE OF VANUATU.” In Economic Vulnerability and Resilience of Small States, 135–48. University of Malta. Islands and Small States Institute & The Commonwealth Secretariat.
Jhoo, J-W, J. P. Freeman, C. Y. W. Ang, and J. J. Mihalov. 2006. “Assessment of Kavalactones in Kava Beverage Products and Aqueous Infusions.” Journal of Food Science 71 (6): C345–51. https://doi.org/10.1111/j.1750-3841.2006.00102.x.
Jhoo, Jin-Woo, James P. Freeman, Thomas M. Heinze, Joanna D. Moody, Laura K. Schnackenberg, Richard D. Beger, Klaus Dragull, Chung-Shih Tang, and Catharina Y. W. Ang. 2006. “In Vitro Cytotoxicity of Nonpolar Constituents from Different Parts of Kava Plant (Piper Methysticum).” Journal of Agricultural and Food Chemistry 54 (8): 3157–62. https://doi.org/10.1021/jf051853j.
Johana, A. Mendes, Y. Ekowati Nurhening, S. Susanti Diana, Sembiring Jefri, Prasetia Andri, and Widijastuti Rosmala. 2018. “The Potential Leaves Extract of Piper Methysticum (piperaceae) as Botanical Insecticide against Crocidolomia Pavonana (f.) Larvae Mortality (lepidoptera:crambidae).” E3S Web of Conferences 73: 06015. https://doi.org/10.1051/e3sconf/20187306015.
Johnson, Benjamin M., Sheng-Xiang Qiu, Shide Zhang, Fagen Zhang, Joanna E. Burdette, Linning Yu, Judy L. Bolton, and Richard B. van Breemen. 2003. “Identification of Novel Electrophilic Metabolites of Piper Methysticum Forst (Kava).” Chemical Research in Toxicology 16 (6): 733–40. https://doi.org/10.1021/tx020113r.
Johnson, Thomas E., David Hermanson, Lei Wang, Fekadu Kassie, Pramod Upadhyaya, Michael G. O’Sullivan, Stephen S. Hecht, Junxuan Lu, and Chengguo Xing. 2011. “Lung Tumorigenesis Suppressing Effects of a Commercial Kava Extract and Its Selected Compounds in A/J Mice.” The American Journal of Chinese Medicine 39 (4): 727–42. https://doi.org/10.1142/S0192415X11009202.
Johnson, Thomas E., Fekadu Kassie, M. Gerard O’Sullivan, Mesfin Negia, Timothy E. Hanson, Pramod Upadhyaya, Peter P. Ruvolo, Stephen S. Hecht, and Chengguo Xing. 2008. “Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone plus Benzo[a]pyrene–Induced Lung Tumorigenesis in A/J Mice.” Cancer Prevention Research 1 (6): 430–38. https://doi.org/10.1158/1940-6207.CAPR-08-0027.
Jokhan, Anjeela D., and Patricia A. McLenachan. 2004. “Genetic Fingerprinting of Fijian Kava.” The South Pacific Journal of Natural and Applied Sciences 22 (1): 43–45. https://doi.org/10.1071/sp04008.
Jussofie, A., A. Schmiz, and C. Hiemke. 1994. “Kavapyrone Enriched Extract from Piper Methysticum as Modulator of the GABA Binding Site in Different Regions of Rat Brain.” Psychopharmacology 116 (4): 469–74. https://doi.org/10.1007/BF02247480.
Kandukuru, P., A. S. Huang, J. Dong, H. C. Bittenbender, and Y. Li. 2009. “Rapid Identification of Bacterial Isolates from Aqueous Kava (Piper Methysticum) Extracts by Polymerase Chain Reaction and DNA Sequencing.” Letters in Applied Microbiology 49 (6): 764–68. https://doi.org/10.1111/j.1472-765X.2009.02739.x.
Kautu, Bwarenaba B., Juliana Phillips, Kellie Steele, M. Shawn Mengarelli, and Eric A. Nord. 2017. “A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis Elegans Neuromuscular Transmission.” Journal of Experimental Neuroscience 11 (June): 1179069517705384. https://doi.org/10.1177/1179069517705384.
“Kava.” n.d. Accessed May 5, 2021. https://www.betterhealth.vic.gov.au/health/healthyliving/kava.
Keledjian, J., P. H. Duffield, D. D. Jamieson, R. O. Lidgard, and A. M. Duffield. 1988. “Uptake into Mouse Brain of Four Compounds Present in the Psychoactive Beverage Kava.” Journal of Pharmaceutical Sciences 77 (12): 1003–6. https://doi.org/10.1002/jps.2600771203.
Ketola, Raimo A., Jenni Viinamäki, Ilpo Rasanen, Anna Pelander, and Sirkka Goebeler. 2015. “Fatal Kavalactone Intoxication by Suicidal Intravenous Injection.” Forensic Science International 249 (April): e7–11. https://doi.org/10.1016/j.forsciint.2015.01.032.
Klaus Dragull Jim Henderson Mel C. Jackson Ed Johnston Jerry Konanui G. David Lin Kepā Maly Scot Nelson Jeri Ooka Tom Osborn Helen Rogers Chung-Shih Tang. 2006. Hawaiian ‘Awa Views of an Ethnobotanical Treasure. Edited by Ed Johnston and Helen Rogers. Association for Hawaiian ‘Awa.
Klohs, M. W., Keller, F., Williams, R. E., Toekes, M. I., Cronheim, G. E. 1959. “A Chemical and Pharmacological Investigation of Piper Methysticum Forst.” Journal of Medicinal and Pharmaceutical Chemistry 1 (1): 95–103. https://doi.org/10.1021/jm50002a007.
Kong, Yulong, Xiaoguang Gao, Changyuan Wang, Chenqing Ning, Kexin Liu, Zhihao Liu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, and Qiang Meng. 2018. “Protective Effects of Yangonin from an Edible Botanical Kava against Lithocholic Acid-Induced Cholestasis and Hepatotoxicity.” European Journal of Pharmacology 824 (April): 64–71. https://doi.org/10.1016/j.ejphar.2018.02.002.
Krum, Bárbara Nunes, Catiuscia Molz de Freitas, Ana Paula Chiapinotto Ceretta, Caroline Pilecco Barbosa, Elizete de Moraes Reis, Rahisa Scussel, Emily da Silva Córneo, Ricardo Andrez Machado-de-Ávila, Aline Augusti Boligon, and Roselei Fachinetto. 2021. “Kava Decreases the Stereotyped Behavior Induced by Amphetamine in Mice.” Journal of Ethnopharmacology 265 (January): 113293. https://doi.org/10.1016/j.jep.2020.113293.
Kubátová, A., D. J. Miller, and S. B. Hawthorne. 2001. “Comparison of Subcritical Water and Organic Solvents for Extracting Kava Lactones from Kava Root.” Journal of Chromatography. A 923 (1-2): 187–94. https://doi.org/10.1016/s0021-9673(01)00979-7.
Kuchta, Kenny, Marie Hladikova, Michael Thomsen, Adolf Nahrstedt, and Mathias Schmidt. 2021. “Kava (Piper Methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness.” Drug Research 71 (2): 83–93. https://doi.org/10.1055/a-1268-7135.
Kuchta, Kenny, Pietro de Nicola, and Mathias Schmidt. 2018. “Randomized, Dose-Controlled Double-Blind Trial: Efficacy of an Ethanolic Kava (Piper Methysticum Rhizome) Extract for the Treatment of Anxiety in Elderly Patients: Kava Extract for Anxiety.” Traditional & Kampo Medicine 5 (1): 3–10. https://doi.org/10.1002/tkm2.1079.
Kuchta, Kenny, Mathias Schmidt, and Adolf Nahrstedt. 2015. “German Kava Ban Lifted by Court: The Alleged Hepatotoxicity of Kava (Piper Methysticum) as a Case of Ill-Defined Herbal Drug Identity, Lacking Quality Control, and Misguided Regulatory Politics.” Planta Medica 81 (18): 1647–53. https://doi.org/10.1055/s-0035-1558295.
Kumagai, Momochika, Keisuke Nishikawa, Takashi Mishima, Izumi Yoshida, Masahiro Ide, Akio Watanabe, Kazuhiro Fujita, and Yoshiki Morimoto. 2020. “Fluorinated Kavalactone Inhibited RANKL-Induced Osteoclast Differentiation of RAW264 Cells.” Biological & Pharmaceutical Bulletin 43 (5): 898–903. https://doi.org/10.1248/bpb.b20-00063.
LaPorte, E., J. Sarris, C. Stough, and A. Scholey. 2011. “Neurocognitive Effects of Kava (Piper Methysticum): A Systematic Review.” Human Psychopharmacology 26 (2): 102–11. https://doi.org/10.1002/hup.1180.
Lasme, Privat, Fabrice Davrieux, Didier Montet, and Vincent Lebot. 2008. “Quantification of Kavalactones and Determination of Kava (Piper Methysticum) Chemotypes Using near-Infrared Reflectance Spectroscopy for Quality Control in Vanuatu.” Journal of Agricultural and Food Chemistry 56 (13): 4976–81. https://doi.org/10.1021/jf800439g.
Lebot, V. 1996. “Evidence for Conspecificity of Piper Methysticum Forst. F. and Piper Wichmannii C. DC.” Biochemical Systematics and Ecology. https://doi.org/10.1016/s0305-1978(97)81216-1.
Lebot, V., T. K. T. Do, and L. Legendre. 2014. “Detection of Flavokavins (A, B, C) in Cultivars of Kava (Piper Methysticum) Using High Performance Thin Layer Chromatography (HPTLC).” Food Chemistry 151 (May): 554–60. https://doi.org/10.1016/j.foodchem.2013.11.120.
Lebot, Vincent. 1995. “The Origin And Distribution Of Kava.” Canberra Anthropology 18 (1-2): 20–33. https://doi.org/10.1080/03149099509508407.
Lebot, Vincent, z. Mallikarjuna K. Aradhya, and Richard M. Manshardt. 1991. “Geographic Survey of Genetic Variation in Kava (Piper Methysticum Forst. F. and P. Wichmannii C. DC.).” Pacific Science 45 (2): 169–85. http://hdl.handle.net/10125/518.
Lebot Vincent, Cabalion Pierre. 1988. KAVAS OF VANUATU Cultivars of Piper Methysticum Forst. South Pacific Commission Technical Paper.
Lebot, Vincent, Juliane Kaoh, and Laurent Legendre. 2020. “High-Throughput Analysis of Flavokawains in Kava (Piper Methysticum Forst. F.) Roots, Chips and Powders and Correlations with Their Acetonic Extracts Absorbance.” Food Analytical Methods 13 (8): 1583–93. https://doi.org/10.1007/s12161-020-01781-9.
Lebot, Vincent, and Laurent Legendre. 2016. “Comparison of Kava (Piper Methysticum Forst.) Varieties by UV Absorbance of Acetonic Extracts and High-Performance Thin-Layer Chromatography.” Journal of Food Composition and Analysis: An Official Publication of the United Nations University, International Network of Food Data Systems 48 (May): 25–33. https://doi.org/10.1016/j.jfca.2016.01.009.
Lebot, Vincent, and Joël Levesque. 1996. “Genetic Control of Kavalactone Chemotypes in Piper Methysticum Cultivars.” Phytochemistry 43 (2): 397–403. https://doi.org/10.1016/0031-9422(96)00209-9.
Lebot, Vincent, Dennis J. McKenna, Ed Johnston, Qun Yi Zheng, and Doug McKern. 1999. “Morphological, Phytochemical, and Genetic Variation in Hawaiian Cultivars of ’Awa (Kava,Piper Methysticum, Piperaceae).” Economic Botany 53 (4): 407–18. https://doi.org/10.1007/bf02866720.
Lebot, Vincent, Serge Michalet, and Laurent Legendre. 2019. “Kavalactones and Flavokavins Profiles Contribute to Quality Assessment of Kava (Piper Methysticum G. Forst.), the Traditional Beverage of the Pacific.” Beverages 5 (2): 34. https://doi.org/10.3390/beverages5020034.
Lebot, Vincent, and Patricia Siméoni. 2004. “Is the Quality of Kava (Piper Methysticum Forst. F.) Responsible for Different Geographical Patterns?” Ethnobotany Research and Applications. https://scholarspace.manoa.hawaii.edu/handle/10125/135.
Lehrl, Siegfried. 2004. “Clinical Efficacy of Kava Extract WS 1490 in Sleep Disturbances Associated with Anxiety Disorders. Results of a Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.” Journal of Affective Disorders 78 (2): 101–10. https://doi.org/10.1016/s0165-0327(02)00238-0.
Lemert, E. M. 1967. “Secular Use of Kava in Tonga.” Quarterly Journal of Studies on Alcohol 28 (2): 328–41. https://www.ncbi.nlm.nih.gov/pubmed/6049173.
Lester, R. H. 1941. “Kava Drinking in Vitilevu, Fiji.” Oceania; a Journal Devoted to the Study of the Native Peoples of Australia, New Guinea, and the Islands of the Pacific 12 (2): 97–121. http://www.jstor.org/stable/40327938.
Lhuissier, Tiphaine, Pierre-Edouard Mercier, Serge Michalet, Vincent Lebot, and Laurent Legendre. 2017. “Colorimetric Assessment of Kava (Piper Methysticum Forst.) Quality.” Journal of Food Composition and Analysis: An Official Publication of the United Nations University, International Network of Food Data Systems 59 (June): 27–34. https://doi.org/10.1016/j.jfca.2017.02.005.
Li, Juan, Lei Zheng, Mi Yan, Jing Wu, Yongqing Liu, Xiaona Tian, Wen Jiang, Lu Zhang, and Rongmei Wang. 2020. “Activity and Mechanism of Flavokawain A in Inhibiting P-Glycoprotein Expression in Paclitaxel Resistance of Lung Cancer.” Oncology Letters 19 (1): 379–87. https://doi.org/10.3892/ol.2019.11069.
Li, Xuesen, Zhongbo Liu, Xia Xu, Christopher A. Blair, Zheng Sun, Jun Xie, Michael B. Lilly, and Xiaolin Zi. 2012. “Kava Components down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice.” PloS One 7 (2): e31213. https://doi.org/10.1371/journal.pone.0031213.
Li, Xuesen, Xia Xu, Tao Ji, Zhongbo Liu, Mai Gu, Bang H. Hoang, and Xiaolin Zi. 2014. “Dietary Feeding of Flavokawain A, a Kava Chalcone, Exhibits a Satisfactory Safety Profile and Its Association with Enhancement of Phase II Enzymes in Mice.” Toxicology Reports 1: 2–11. https://doi.org/10.1016/j.toxrep.2014.02.002.
Li, Xuesen, Noriko N. Yokoyama, Saiyang Zhang, Lina Ding, Hong-Min Liu, Michael B. Lilly, Dan Mercola, and Xiaolin Zi. 2015. “Flavokawain A Induces deNEDDylation and Skp2 Degradation Leading to Inhibition of Tumorigenesis and Cancer Progression in the TRAMP Transgenic Mouse Model.” Oncotarget 6 (39): 41809–24. https://doi.org/10.18632/oncotarget.6166.
Li, Yan, Hu Mei, Qiangen Wu, Suhui Zhang, Jia-Long Fang, Leming Shi, and Lei Guo. 2011. “Methysticin and 7,8-Dihydromethysticin Are Two Major Kavalactones in Kava Extract to Induce CYP1A1.” Toxicological Sciences: An Official Journal of the Society of Toxicology 124 (2): 388–99. https://doi.org/10.1093/toxsci/kfr235.
Ligresti, Alessia, Rosaria Villano, Marco Allarà, István Ujváry, and Vincenzo Di Marzo. 2012. “Kavalactones and the Endocannabinoid System: The Plant-Derived Yangonin Is a Novel CB₁ Receptor Ligand.” Pharmacological Research: The Official Journal of the Italian Pharmacological Society 66 (2): 163–69. https://doi.org/10.1016/j.phrs.2012.04.003.
Lim, Steven T. S., Klaus Dragull, Chung-Shih Tang, Harry C. Bittenbender, Jimmy T. Efird, and Pratibha V. Nerurkar. 2007. “Effects of Kava Alkaloid, Pipermethystine, and Kavalactones on Oxidative Stress and Cytochrome P450 in F-344 Rats.” Toxicological Sciences: An Official Journal of the Society of Toxicology 97 (1): 214–21. https://doi.org/10.1093/toxsci/kfm035.
Lin, Chien-Tsong, K. Jayabal Senthil Kumar, Yen-Hsueh Tseng, Zi-Jie Wang, Mu-Yun Pan, Jun-Hong Xiao, Shih-Chang Chien, and Sheng-Yang Wang. 2009. “Anti-Inflammatory Activity of Flavokawain B from Alpinia Pricei Hayata.” Journal of Agricultural and Food Chemistry 57 (14): 6060–65. https://doi.org/10.1021/jf900517d.
Lindstrom, Lamont. 2009. “Kava Pirates in Vanuatu?” International Journal of Cultural Property 16 (03): 291–308. https://doi.org/10.1017/S0940739109990208.
Liu, Ying, Jensen A. Lund, Susan J. Murch, and Paula N. Brown. 2018. “Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper Methysticum (Kava).” Planta Medica 84 (16): 1213–18. https://doi.org/10.1055/a-0637-2400.
(Apo) Aporosa, S., and Matt Tomlinson. 2014. “Kava Hangover and Gold-Standard Science.” Anthropologica 56 (1): 163–75. https://doi.org/10.1353/ant.2014.0014.
Abdel Jaleel, Gehad A., Dalia O. Saleh, and Sally A. El-Awdan. 2013. “Antihyperglycaemic Effect of Kava Kava (piper Methysticum) in Streptozotocin- Induced Diabetic Rats.” Der Pharmacia Lettre 5 (5): 104–10.
Abu, Nadiah, M. Nadeem Akhtar, Swee Keong Yeap, Kian Lam Lim, Wan Yong Ho, Aimi Jamil Zulfadli, Abdul Rahman Omar, Mohd Roslan Sulaiman, Mohd Puad Abdullah, and Noorjahan Banu Alitheen. 2014. “Flavokawain A Induces Apoptosis in MCF-7 and MDA-MB231 and Inhibits the Metastatic Process in Vitro.” PloS One 9 (10): e105244. https://doi.org/10.1371/journal.pone.0105244.
Abu, Nadiah, Wan Yong Ho, Swee Keong Yeap, M. Nadeem Akhtar, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2013. “The Flavokawains: Uprising Medicinal Chalcones.” Cancer Cell International 13 (1): 102. https://doi.org/10.1186/1475-2867-13-102.
Abu, Nadiah, Nurul Elyani Mohamed, Swee Keong Yeap, Kian Lam Lim, M. Nadeem Akhtar, Aimi Jamil Zulfadli, Beh Boon Kee, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2015. “In Vivo Antitumor and Antimetastatic Effects of Flavokawain B in 4T1 Breast Cancer Cell-Challenged Mice.” Drug Design, Development and Therapy 9 (March): 1401–17. https://doi.org/10.2147/DDDT.S67976.
Abu, Nadiah, Nurul Elyani Mohameda, Nirosha Tangarajoo, Swee Keong Yeap, M. Nadeem Akhtar, Mohd Puad Abdullah, Abdul Rahman Omar, and Noorjahan Banu Alitheen. 2015. “In Vitro Toxicity and in Vivo Immunomodulatory Effects of Flavokawain A and Flavokawain B in Balb/C Mice.” Natural Product Communications 10 (7): 1199–1202. https://doi.org/10.1177/1934578X1501000716.
Ambrose, W. 1991. “Manus, Mortars and the Kava Concoction.” https://www.semanticscholar.org/paper/097e6b89e9b9b7cd01a76f4f8bc07e300fbca9ca.
Amdidouche-Hussain’I, Didja, and Joel Levesque. 1997. “Selection of Kavalactones by Complexation of Kava Extract with C Yclodextrins.” Drug Development and Industrial Pharmacy 23 (12): 1223–26. https://doi.org/10.3109/03639049709146161.
Anke, J., S. Fu, and I. Ramzan. 2006. “Kavalactones Fail to Inhibit Alcohol Dehydrogenase in Vitro.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 13 (3): 192–95. https://doi.org/10.1016/j.phymed.2004.07.005.
Anke, Jennifer, and Iqbal Ramzan. 2004a. “Pharmacokinetic and Pharmacodynamic Drug Interactions with Kava (Piper Methysticum Forst. F.).” Journal of Ethnopharmacology 93 (2-3): 153–60. https://doi.org/10.1016/j.jep.2004.04.009.
Anke, Jennifer, and Iqqbal Ramzan. 2004b. “Kava Hepatotoxicity: Are We Any Closer to the Truth?” Planta Medica 70: 193–96. https://doi.org/10.1055/s-2004-815533.
Apo Aporosa, S. 2011. “Apososa S. ‘Apo’ - 2011 - Is Kava Alcohol The Myths and the Facts.pdf.” Pacific Health Dialog 17 (1): 157–64. https://pubmed.ncbi.nlm.nih.gov/23008981/.
Apo’Aporosa, S. 2015. “Yaqona (kava) as a Symbol of Cultural Identity.” S. ‘. Aporosa.
Aporosa, A. S. 2019. “Kava, the Devil, and the Snake: Pentecostal Iconoclasm in Contemporary Fiji.” University of Auckland.
Aporosa, Apo. 2019. “Australia’s Discussion of Kava Imports Reflects Lack of Cultural Understanding.” The Conversation, June 9, 2019. http://theconversation.com/australi...eflects-lack-of-cultural-understanding-115662.
Aporosa, Apo S., Martin Atkins, and Richard Brunton. 2020. “Kava Drinking in Traditional Settings: Towards Understanding Effects on Cognitive Function.” Human Psychopharmacology 35 (2): e2725. https://doi.org/10.1002/hup.2725.
Aporosa, S. 2017. “Understanding Cognitive Functions Related to Driving Following Kava (Piper Methysticum) Use at Traditional Consumption Volumes.” In British Association for Psychopharmacology Conference, A84–A84. SAGE Publications. https://researchcommons.waikato.ac.nz/handle/10289/11307.
———. 2018. “Improving Road Safety and Health: Understanding Kava’s Impact on Driver Fitness.” University of Waikato. https://researchcommons.waikato.ac.nz/handle/10289/12947.
———. 2019. “Cognitive Functions Associated with Consumption of Traditional Volumes of Kava (Piper Methysticum): A Feasibility Study.” In British Association for Psychopharmacology. researchcommons.waikato.ac.nz. https://researchcommons.waikato.ac.nz/handle/10289/12780.
Aporosa, S. Apo. 2019a. “Kava and Ethno-Cultural Identity in Oceania.” In The Palgrave Handbook of Ethnicity, edited by Steven Ratuva, 1–15. Singapore: Springer Singapore. https://doi.org/10.1007/978-981-13-0242-8_134-1.
———. 2019b. “De-Mythologizing and Re-Branding of Kava as the New ‘world Drug’ of Choice.” Drug Science, Policy and Law 5 (January): 2050324519876131. https://doi.org/10.1177/2050324519876131.
Aporosa, S. Apo, Martin Atkins, and Jess N. Leov. 2021. “Decolonising Quantitative Methods within a Pacific Research Space to Explore Cognitive Effects Following Kava Use.” Journal of Interdisciplinary Research 5 (1). https://doi.org/10.26021/10642.
Aporosa, S. ’apo'. 2014. “YAQONA (KAVA) AND EDUCATION IN FIJI:INVESTIGATING ‘CULTURAL COMPLEXITIES’FROM A POST-DEVELOPMENT PERSPECTIVE.”
Aporosa, S., and Jacinta Forde. 2019. “Māori and Kava: New Drug Fashion or Re-Engagement With’kawa'?” Pacific Dynamics 3 (1): 72–85. https://researchcommons.waikato.ac.nz/handle/10289/12952.
Aporosa, S. G. 2008. Yaqona (Kava) and Education in Fiji: A Clash of Cultures? VDM Verlag.
Ashraf-Khorassani, M., L. T. Taylor, and M. Martin. 1999. “Supercritical Fluid Extraction of Kava Lactones from Kava Root and Their Separation via Supercritical Fluid Chromatography.” Chromatographia 50: 287–92. https://doi.org/10.1007/BF02490830.
Backhaul, Cord, and Josef Krieglstein. 1992. “Extract of Kava ( Piper Methysticum) and Its Methysticin Constituents Protect Brain Tissue against Ischemic Damage in Rodents.” European Journal ~>~ Pharmacoloj, % 215: 265269.
Backleh, Marlène, Perihan Ekici, Günther Leupold, and Harun Parlar. 2003. “Quantitative Elimination of Flavokavines A and B from Kava Kava (Piper Methysticum G. Forst) by Isoelectric Focused Adsorptive Bubble Separation.” Die Naturwissenschaften 90 (8): 366–69. https://doi.org/10.1007/s00114-003-0440-5.
Baker, Jonathan D. 2011. “Tradition and Toxicity: Evidential Cultures in the Kava Safety Debate.” Social Studies of Science 41 (3): 361–84. https://doi.org/10.1177/0306312710395341.
———. 2012. “Pills, Potions, Products: Kava’s Transformations in New and Nontraditional Contexts.” The Contemporary Pacific 24 (2): 233–65. https://doi.org/10.1353/cp.2012.0026.
Balick, Michael J., and Roberta Lee. 2002. “Traditional Use of Sakau (kava) in Pohnpei: Lessons for Integrative Medicine.” Alternative Therapies in Health and Medicine 8 (4): 96–98. https://www.ncbi.nlm.nih.gov/pubmed/12126179.
Balick, Michael J & Lee, Robert A. 2009. “The Sacred Root.” In Ethnobotany of Pohnpei, 165–203. University of Hawaii Press.
Barguil, Yann, Erwan Choblet, Sébastien Warter, and Mohammed Nour. 2013. “Kava Ichthyosis: A Nitric Oxide Synthase Inhibition?” Annales de Toxicologie Analytique 25 (4): 165–68. https://doi.org/10.1051/ata/2014001.
Barnes, Joanne, Linda A. Anderson, and J. D. Phillipson. 2007. “Kava - Overview.” In Herbal Medicines, 389–402. 3rd Ed. Grayslake, IL: Pharmaceutical Press.
Bauer, Rudolf, Brigitte & Kopp, and A. Nahrstedt. 2003. “Relevant Hepatotoxic Effects of Kava Still Need to Be Proven: A Statement of the Society for Medicinal Plant Research.” Planta Medica 69 (11): 971–72. https://doi.org/10.1055/s-2003-45140.
Baum, S. S., R. Hill, and H. Rommelspacher. 1998. “Effect of Kava Extract and Individual Kavapyrones on Neurotransmitter Levels in the Nucleus Accumbens of Rats.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 22 (7): 1105–20. https://doi.org/10.1016/s0278-5846(98)00062-1.
Becker, Matheus William, Emerson Matheus Silva Lourençone, Alexandre Formighieri De Mello, Aline Branco, Edison Moraes Rodrigues Filho, Celso Ronaldo Blatt, Carlos Augusto Mallmann, Maurício Schneider, Rita Catalina Aquino Caregnato, and Carine Raquel Blatt. 2019. “Liver Transplantation and the Use of KAVA: Case Report.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 56 (March): 21–26. https://doi.org/10.1016/j.phymed.2018.08.011.
Behl, Mamta, Abraham Nyska, Rajendra S. Chhabra, Gregory S. Travlos, Laurene M. Fomby, Barney R. Sparrow, Milton R. Hejtmancik, and Po C. Chan. 2011. “Liver Toxicity and Carcinogenicity in F344/N Rats and B6C3F1 Mice Exposed to Kava Kava.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49 (11): 2820–29. https://doi.org/10.1016/j.fct.2011.07.067.
Berry, Jonna, Ashley Gilbert, and Justin Grodnitzky. 2019. “Cases of Kava Impairment in Iowa Drivers.” Journal of Forensic Sciences 64 (6): 1943–49. https://doi.org/10.1111/1556-4029.14130.
BfArM. 2002. “Kava Removal.” http://lrd.spc.int/ahp-publications/doc_download/578-gr-cis-bfarm-kava-removal.
Bian, Tengfei, Pedro Corral, Yuzhi Wang, Jordy Botello, Rick Kingston, Tyler Daniels, Ramzi G. Salloum, et al. 2020. “Kava as a Clinical Nutrient: Promises and Challenges.” Nutrients 12 (10). https://doi.org/10.3390/nu12103044.
Bilia, Anna Rita, Sandra Gallon, and Franco F. Vincieri. 2002. “Kava-Kava and Anxiety: Growing Knowledge about the Efficacy and Safety.” Life Sciences 70 (22): 2581–97. https://doi.org/10.1016/s0024-3205(02)01555-2.
Bilia, Anna Rita, Luca Scalise, Maria Camilla Bergonzi, and Franco F. Vincieri. 2004. “Analysis of Kavalactones from Piper Methysticum (kava-Kava).” Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 812 (1-2): 203–14. https://doi.org/10.1016/j.jchromb.2004.07.038.
Bird, Gail. 2016. “Import Restrictions: Kava and Khat.” The Office of Drug Control. December 7, 2016. https://www.odc.gov.au/import-restrictions-kava-and-khat.
Boerner, R. J. 2001. “Kava Kava in the Treatment of Generalized Anxiety Disorder, Simple Phobia and Specific Social Phobia.” Phytotherapy Research: PTR 15 (7): 646–47. https://doi.org/10.1002/ptr.1006.
Boerner, R. J., H. Sommer, W. Berger, U. Kuhn, U. Schmidt, and M. Mannel. 2003. “Kava-Kava Extract LI 150 Is as Effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-Week Randomized, Double-Blind Multi-Centre Clinical Trial in 129 out-Patients.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 10 Suppl 4: 38–49. https://doi.org/10.1078/1433-187x-00309.
Boerner, Reinhard J., and Stephan Klement. 2004. “Attenuation of Neuroleptic-Induced Extrapyramidal Side Effects by Kava Special Extract WS 1490.” Wiener Medizinische Wochenschrift 154 (21-22): 508–10. https://doi.org/10.1007/s10354-004-0115-7.
Boonen, G., B. Ferger, K. Kuschinsky, and H. Häberleinl. 1998. “In Vivo Effects of the Kavapyrones (+)-Dihydromethysticin And(±)-Kavain on Dopamine, 3,4-Dihydroxyphenylacetic Acid, Serotonin and 5-Hydroxyindoleacetic Acid Levels in Striatal and Cortical Brain Regions.” Planta Medica 64: 507–10.
Boonen, Georg, and Hanns Hberlein. 1998. “Influence of Genuine Kavapyrone Enantiomerson the GABAA Binding Site.” Planta Medica 64: 504–6.
Botello, Jordy F., Pedro Corral, Tengfei Bian, and Chengguo Xing. 2020. “Kava and Its Kavalactones Inhibit Norepinephrine-Induced Intracellular Calcium Influx in Lung Cancer Cells.” Planta Med 86 (1): 26–31. https://doi.org/10.1055/a-1035-5183.
Brown, Amy C., Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J. Craig, Klaus Dragull, Arieh M. Levine, and Jonathan D. Baker. 2007. “Traditional Kava Beverage Consumption and Liver Function Tests in a Predominantly Tongan Population in Hawaii.” Clinical Toxicology 45 (5): 549–56. https://doi.org/10.1080/15563650701365875.
Butt, Julia. 2019. Kava Usage in Aboriginal and Pacific Islander Communities in Australia. National Drug Research Institute.
Cairney, Sheree, Alan R. Clough, Paul Maruff, Alex Collie, Bart J. Currie, and Jon Currie. 2003. “Saccade and Cognitive Function in Chronic Kava Users.” Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28 (2): 389–96. https://doi.org/10.1038/sj.npp.1300052.
Cairney, Sheree, Paul Maruff, and Alan R. Clough. 2002. “The Neurobehavioural Effects of Kava.” The Australian and New Zealand Journal of Psychiatry 36 (5): 657–62. https://doi.org/10.1046/j.1440-1614.2002.01027.x.
Capasso, A., and L. Sorrentino. 2005. “Pharmacological Studies on the Sedative and Hypnotic Effect of Kava Kava and Passiflora Extracts Combination.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 12 (1-2): 39–45. https://doi.org/10.1016/j.phymed.2004.03.006.
Catchpole, O. J., N. B. Perry, B. M. T. da Silva, J. B. Grey, and B. M. Smallfield. 2002. “Supercritical Extraction of Herbs I: Saw Palmetto, St John’s Wort, Kava Root, and Echinacea.” The Journal of Supercritical Fluids 22 (2): 129–38. https://doi.org/10.1016/S0896-8446(01)00110-3.
Cawte, John. 1986. “Parameters of Kava Used as a Challenge to Alcohol.” The Australian and New Zealand Journal of Psychiatry 20 (1): 70–76. https://doi.org/10.3109/00048678609158867.
Celentano, Antonio, Andrew Tran, Claire Testa, Krishen Thayanantha, William Tan-Orders, Stephanie Tan, Mitali Syamal, Michael J. McCullough, and Tami Yap. 2019. “The Protective Effects of Kava (Piper Methysticum) Constituents in Cancers: A Systematic Review.” Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 48 (7): 510–29. https://doi.org/10.1111/jop.12900.
Celentano, Antonio, Callisthenis Yiannis, Rita Paolini, Pangzhen Zhang, Camile S. Farah, Nicola Cirillo, Tami Yap, and Michael McCullough. 2020. “Kava Constituents Exert Selective Anticancer Effects in Oral Squamous Cell Carcinoma Cells in Vitro.” Scientific Reports 10 (1): 1–11. https://doi.org/10.1038/s41598-020-73058-4.
Chambers, Megan I., Amy M. Osborne, and Rabi A. Musah. 2019. “Rapid Detection and Validated Quantification of Psychoactive Compounds in Complex Plant Matrices by Direct Analysis in Real Time-High Resolution Mass Spectrometry - Application to ‘Kava’ Psychoactive Pepper Products.” Rapid Communications in Mass Spectrometry: RCM 33 (24): 1915–25. https://doi.org/10.1002/rcm.8532.
Chaurasiya, Narayan D., Francisco León, Yuanqing Ding, Isabel Gómez-Betancur, Dora Benjumea, Larry A. Walker, Stephen J. Cutler, and Babu L. Tekwani. 2017. “Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia Alpinia, with Human Monoamine Oxidase-A and Oxidase-B.” Evidence-Based Complementary and Alternative Medicine: eCAM 2017 (August): 4018724. https://doi.org/10.1155/2017/4018724.
Chou, Tsui-Wei, Jia-Hua Feng, Chi-Chang Huang, Ya-Wen Cheng, Shih-Chang Chien, Sheng-Yang Wang, and Lie-Fen Shyur. 2013. “A Plant Kavalactone Desmethoxyyangonin Prevents Inflammation and Fulminant Hepatitis in Mice.” PloS One 8 (10): e77626. https://doi.org/10.1371/journal.pone.0077626.
Chua, Han Chow, Emilie T. H. Christensen, Kirsten Hoestgaard-Jensen, Leonny Y. Hartiadi, Iqbal Ramzan, Anders A. Jensen, Nathan L. Absalom, and Mary Chebib. 2016. “Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.” PloS One 11 (6): e0157700. https://doi.org/10.1371/journal.pone.0157700.
Clayton, Natasha P., Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan, and Abraham Nyska. 2007. “Immunohistochemical Analysis of Expressions of Hepatic Cytochrome P450 in F344 Rats Following Oral Treatment with Kava Extract.” Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft Fur Toxikologische Pathologie 58: 223–36. https://doi.org/10.1016/j.etp.2006.08.002.
Clouatre, Dallas L. 2004. “Kava Kava: Examining New Reports of Toxicity.” Toxicology Letters 150: 85–96. https://doi.org/10.1016/j.toxlet.2003.07.005.
Clough, A. R., S. P. Jacups, Z. Wang, C. B. Burns, R. S. Bailie, S. J. Cairney, A. Collie, T. Guyula, S. P. McDonald, and B. J. Currie. 2003. “Health Effects of Kava Use in an Eastern Arnhem Land Aboriginal Community.” Internal Medicine Journal 33 (8): 336–40. https://doi.org/10.1046/j.1444-0903.2003.00405.x.
Clough, A. R., K. Rowley, and K. O’Dea. 2004. “Kava Use, Dyslipidaemia and Biomarkers of Dietary Quality in Aboriginal People in Arnhem Land in the Northern Territory (NT), Australia.” European Journal of Clinical Nutrition 58 (7): 1090–93. https://doi.org/10.1038/sj.ejcn.1601921.
Clough, Alan. 2003. “Enough! Or Too Much. What Is ‘Excessive’ Kava Use in Arnhem Land?” Drug and Alcohol Review 22 (1): 43–51. https://doi.org/10.1080/0959523021000059820.
Clough, Alan R., Sheree Cairney, Paul Maruff, Chris B. Burns, and Bart J. Currie. 2001. “Possible Toxicity and Withdrawal Seizures in Aboriginal Kava Drinkers in Arnhem Land, (Australia).” South Pacific Journal of Psychology 13: 26–33. https://doi.org/10.1017/S025754340000033X.
Connell, John. 2007. “Towards Free Trade in the Pacific? The Genesis of the ‘Kava-Biscuit War’ between Fiji and Vanuatu.” Geographical Research 45 (1): 1–12. https://doi.org/10.1111/j.1745-5871.2007.00425.x.
Connor, K. M., J. R. Davidson, and L. E. Churchill. 2001. “Adverse-Effect Profile of Kava.” CNS Spectrums 6 (10): 848, 850–53. https://doi.org/10.1017/s109285290000167x.
Connor, K. M., and J. R. T. Davidson. 2002. “A Placebo-Controlled Study of Kava Kava in Generalized Anxiety Disorder.” International Clinical Psychopharmacology 17 (4): 185–88. https://doi.org/10.1097/00004850-200207000-00005.
Connor, Kathryn M., Victoria Payne, and Jonathan R. T. Davidson. 2006. “Kava in Generalized Anxiety Disorder: Three Placebo-Controlled Trials.” International Clinical Psychopharmacology 21 (5): 249–53. https://doi.org/10.1097/00004850-200609000-00001.
Costa, Willian Richardes, Lucas Rossi Sartori, and José C. Tavares Carvalho. 2010. “Study of In Vitro and In Vivo Extraction of Kavalactones of Pharmaceutical Form Containing Ground Plant Drug (Piper Methysticum G. Forster).” Latin American Journal of Pharmacy 29 (2): 289–92. https://www.academia.edu/download/49124391/Kavalactones_LAJP.pdf.
Côté, Cynthia S., Christine Kor, Jon Cohen, and Karine Auclair. 2004. “Composition and Biological Activity of Traditional and Commercial Kava Extracts.” Biochemical and Biophysical Research Communications 322 (1): 147–52. https://doi.org/10.1016/j.bbrc.2004.07.093.
Coulter, David, Tamayo Carmen Sotheeswaran Subramaniam, Catherine Ulbricht, and World Health Organization. 2007. “Assessment of the Risk of Hepatotoxicity with Kava Products.pdf.” World Health Organization.
Cox, Paul Alan, and Lisa O’Rourke. 1987. “Kava (Piper Methysticum, Piperaceae).” Economic Botany 41 (3): 452–54. http://www.jstor.org/stable/4254999.
D. Schmitz ,CL Zhang ,SS Chatterjee &U. Heinemann. 1995. “Effects of Methysticin on Three Different Models of Seizure like Events Studied in Rat Hippocampal and Entorhinal Cortex Slices.” Naunyn-Schmiedeberg’s Archives of Pharmacology 351: 348–55. https://doi.org/10.1007/BF00169074.
Dai, Jun-Qi, Yi-Gang Huang, and Ai-Na He. 2015. “Dihydromethysticin Kavalactone Induces Apoptosis in Osteosarcoma Cells through Modulation of PI3K/Akt Pathway, Disruption of Mitochondrial Membrane Potential and Inducing Cell Cycle Arrest.” International Journal of Clinical and Experimental Pathology 8 (5): 4356–66. https://www.ncbi.nlm.nih.gov/pubmed/26191127.
Danan, Gaby, and Rolf Teschke. 2015. “RUCAM in Drug and Herb Induced Liver Injury: The Update.” International Journal of Molecular Sciences 17 (1). https://doi.org/10.3390/ijms17010014.
Davies, L. P., C. A. Drew, P. Duffield, G. A. Johnston, and D. D. Jamieson. 1992. “Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain.” Pharmacology & Toxicology 71 (2): 120–26. https://doi.org/10.1111/j.1600-0773.1992.tb00530.x.
De Leo, V., A. la Marca, G. Morgante, D. Lanzetta, P. Florio, and F. Petraglia. 2001. “Evaluation of Combining Kava Extract with Hormone Replacement Therapy in the Treatment of Postmenopausal Anxiety.” Maturitas 39 (2): 185–88. https://doi.org/10.1016/s0378-5122(01)00197-9.
Denery, Judith R., Klaus Dragull, C. S. Tang, and Qing X. Li. 2004. “Pressurized Fluid Extraction of Carotenoids from Haematococcus Pluvialis and Dunaliella Salina and Kavalactones from Piper Methysticum.” Analytica Chimica Acta 501 (2): 175–81. https://doi.org/10.1016/j.aca.2003.09.026.
Denham, Alison, Michael McIntyre, and Julie Whitehouse. 2002. “Kava—the Unfolding Story: Report on a Work-in-Progress.” The Journal of Alternative and Complementary Medicine 8 (3): 237–63. https://doi.org/10.1089/10755530260127943.
Dentali, Steven J., Cristina Amarillas, Tyler Blythe, Paula N. Brown, Anton Bzhelyansky, Christine Fields, Holly E. Johnson, et al. 2018. “Standard Method Performance Requirements (SMPRs®) 2018.005: Determination of Kavalactones And/or Flavokavains from Kava (Piper Methysticum).” Journal of AOAC International 101 (4): 1256–60. https://doi.org/10.5740/jaoacint.smpr2018.005.
Department of Industry, Tourism and Trade. 2020. “KAVA MANAGEMENT ACT 1998.” https://legislation.nt.gov.au/Legislation/KAVA-MANAGEMENT-ACT-1998.
Dharmaratne, H. Ranjith W., N. P. Dhammika Nanayakkara, and Ikhlas A. Khan. 2002. “Kavalactones from Piper Methysticum, and Their 13C NMR Spectroscopic Analyses.” Phytochemistry 59 (4): 429–33. https://doi.org/10.1016/s0031-9422(01)00443-5.
Dietlein, G., and D. Schröder-Bernhardi. 2003. “Doctors’ Prescription Behaviour Regarding Dosage Recommendations for Preparations of Kava Extracts.” Pharmacoepidemiology and Drug Safety 12 (5): 417–21. https://doi.org/10.1002/pds.839.
Dinh, L. D., U. Simmen, K. B. Bueter, B. Bueter, K. Lundstrom, and W. Schaffner. 2001. “Interaction of Various Piper Methysticum Cultivars with CNS Receptors in Vitro.” Planta Medica 67 (4): 306–11. https://doi.org/10.1055/s-2001-14334.
DiSilvestro, Robert A., Wenyi Zhang, and David J. DiSilvestro. 2007. “Kava Feeding in Rats Does Not Cause Liver Injury nor Enhance Galactosamine-Induced Hepatitis.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 45 (7): 1293–1300. https://doi.org/10.1016/j.fct.2007.01.015.
Einbond, L. S., A. Negrin, D. M. Kulakowski, H-A Wu, V. Antonetti, F. Jalees, W. Law, et al. 2017. “Traditional Preparations of Kava (Piper Methysticum) Inhibit the Growth of Human Colon Cancer Cells in Vitro.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 24 (January): 1–13. https://doi.org/10.1016/j.phymed.2016.11.002.
Ernst, E. 2007. “A Re-Evaluation of Kava (Piper Methysticum).” British Journal of Clinical Pharmacology 64 (4): 415–17. https://doi.org/10.1111/j.1365-2125.2007.02932.x.
Ernst, Edzard. 2002. “Second Thoughts about Kava.” The American Journal of Medicine 113 (4): 347–48. https://doi.org/10.1016/S0002-9343(02)01204-4.
Fehoko, E. 2013. “From Kava to Coffee: Tongan Young People in Auckland.” Mana Ngākau: Community Compassion Māori and. https://www.academia.edu/download/33781543/From_Kava_to_Coffee_Tongan_Young_People_in_Auckland.pdf.
Fehoko, E., I. Hafoka, and A. Tecun. 2021. “Holding Tightly onto Land and People During a Pandemic: Kava Pedagogies and Tertiary Learning Relationships in Vahaope.” Researchgate.net. https://www.researchgate.net/profil...ertiary-Learning-Relationships-in-Vahaope.pdf.
Feltenstein, Matt W., L. Corinne Lambdin, M. Ganzera, H. Ranjith, W. Dharmaratne, N. P. Dhammika Nanayakkara, Ikhlas A. Khan, and Kenneth J. Sufka. 2003. “Anxiolytic Properties of Piper Methysticum Extract Samples and Fractions in the Chick Social-Separation-Stress Procedure.” Phytotherapy Research: PTR 17 (3): 210–16. https://doi.org/10.1002/ptr.1107.
Ferreira, Juliana Veloso, Isabella Campolina Pierotte, Gerson Antônio Pianetti, and Isabela Costa César. 2020. “Simultaneous Quantitation of Kavalactones in Kava Dry Extracts: Comparison of Multi-Standards and Single Standard Validation Approaches.” Phytochemical Analysis: PCA, December. https://doi.org/10.1002/pca.3019.
Flynn, Nicole. 2016. “Comparison of the Anxiolytic Effects of Diazepam and Kava on Behaviour in Rats.” Master of Arts, University of Canterbury. http://ir.canterbury.ac.nz/handle/10092/12806.
Foo, H., and J. Lemon. 1997. “Acute Effects of Kava, Alone or in Combination with Alcohol, on Subjective Measures of Impairment and Intoxication and on Cognitive Performance.” Drug and Alcohol Review 16 (2): 147–55. https://doi.org/10.1080/09595239700186441.
Food and Agriculture Organization of the United Nations, and WHO. 2016. “Kava: A Review of the Safety of Traditional and Recreational Beverage Consumption.”
Food Standards Australia New Zealand. 2004. “KAVA A Human Health Risk Assessment.” 30.
Fragoulis, Athanassios, Stephanie Siegl, Markus Fendt, Sandra Jansen, Ulf Soppa, Lars-Ove Brandenburg, Thomas Pufe, Joachim Weis, and Christoph Jan Wruck. 2017. “Oral Administration of Methysticin Improves Cognitive Deficits in a Mouse Model of Alzheimer’s Disease.” Redox Biology 12 (August): 843–53. https://doi.org/10.1016/j.redox.2017.04.024.
Fu, Dong, and Iqbal Ramzan. 2015. “Use of Kava as a Phytotherapeutic Agent and Kava‐Related Hepatotoxicity.” Phytotherapies, 312–29. https://doi.org/10.1002/9781119006039.ch13.
Fu, Peter P., Qingsu Xia, Lei Guo, Hongtao Yu, and Po-Chuen Chan. 2008. “Toxicity of Kava Kava.” Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews 26 (1): 89–112. https://doi.org/10.1080/10590500801907407.
Fu, Shuang, Anthony Rowe, and Iqbal Ramzan. 2012. “Kavalactone Metabolism in the Isolated Perfused Rat Liver.” Phytotherapy Research: PTR 26 (12): 1813–16. https://doi.org/10.1002/ptr.4656.
Garner, L. F., and J. D. Klinger. 1985. “Some Visual Effects Caused by the Beverage Kava.” Ethnopharmacol. 13 (3): 307–11. https://doi.org/10.1016/0378-8741(85)90076-5.
Gastpar, M., and H. D. Klimm. 2003. “Treatment of Anxiety, Tension and Restlessness States with Kava Special Extract WS 1490 in General Practice: A Randomized Placebo-Controlled Double-Blind Multicenter Trial.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 10 (8): 631–39. https://doi.org/10.1078/0944-7113-00369.
Geier, F. P., and T. Konstantinowicz. 2004. “Kava Treatment in Patients with Anxiety.” Phytotherapy Research: PTR 18 (4): 297–300. https://doi.org/10.1002/ptr.1422.
Gendle, M. H., A. K. Stroman, and D. P. Mullin. 2011. “Effect of an Acute Dose of Crude Kava Root Extract on Problem Solving in Healthy Young Adults.” Australian Journal of Medical Herbalism 23 (4): 160–63. https://search.informit.org/doi/abs/10.3316/informit.858304482995950.
Gerren, Andrew. 2017. “Effects of Varietal Diversity on Knowledge of Kava (Piper Methysticum) in the Pacific.” University of Hawaii at Manoa, May. http://128.171.57.22/handle/10125/56539.
Gleitz, J., A. Beile, P. Wilkens, A. Ameri, and Peters T. 1997. “Gleitz1’ et Al. - 1997 - Antithrombotic Action of the Kava Pyrone ()-Kavain Prepared from Piper Methysticum on Human Platelets.” Planta Medica 63 (1): 27–30. https://doi.org/10.1055/s-2006-957597.
Gow, Paul J., Nathan J. Connelly, Richard L. Hill, Peter Crowley, and Peter W. Angus. 2003. “Fatal Fulminant Hepatic Failure Induced by a Natural Therapy Containing Kava.” The Medical Journal of Australia 178 (9): 442–43. https://doi.org/10.5694/j.1326-5377.2003.tb05286.x.
Grace, Robert F. 2003. “Kava Drinking in Vanuatu--a Hospital Based Survey.” Pacific Health Dialog 10 (2): 41–44. https://www.ncbi.nlm.nih.gov/pubmed/18181414.
Gregory, R. J., J. E. Gregory, and J. G. Peck. 1981. “Kava and Prohibition in Tanna, Vanuatu.” British Journal of Addiction 76 (3): 299–313. https://doi.org/10.1111/j.1360-0443.1981.tb00236.x.
Groth-Marnat, G., S. Leslie, and M. Renneker. 1996. “Tobacco Control in a Traditional Fijian Village: Indigenous Methods of Smoking Cessation and Relapse Prevention.” Social Science & Medicine 43 (4): 473–77. https://doi.org/10.1016/0277-9536(95)00425-4.
Grunze, Heinz, Jens Langosch, Karin Schirrmacher, Dieter Bingmann, Jörg von Wegerer, and Jörg Walden. 2001. “Kava Pyrones Exert Effects on Neuronal Transmission and Transmembraneous Cation Currents Similar to Established Mood Stabilizers - a Review.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 25 (8): 1555–70. https://doi.org/10.1016/S0278-5846(01)00208-1.
Guo, Lei, Qiang Shi, Stacey Dial, Qingsu Xia, Nan Mei, Quan-Zhen Li, Po-Chuen Chan, and Peter Fu. 2010. “Gene Expression Profiling in Male B6C3F1 Mouse Livers Exposed to Kava Identifies--Changes in Drug Metabolizing Genes and Potential Mechanisms Linked to Kava Toxicity.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48 (2): 686–96. https://doi.org/10.1016/j.fct.2009.11.050.
Gurgel Andrade Pedrosa, Elaine Cristina, Ana Paula Carvalho Bezerra, Ianara Mendonça da Costa, Francisco Irochima Pinheiro, and Fausto Pierdoná Guzen. 2020. “Neuroprotective Profile of Piper Methysticum (Kava Kava) and Its Effects on the Central Nervous System: A Systematic Review.” Journal of Pharmacological Chemistry and Biological Sciences 2 (1): 55–84. https://doi.org/10.36619/jpcbs.2020.2.56.80.
Gurley, Bill J., Ashley Swain, Martha A. Hubbard, D. Keith Williams, Gary Barone, Faith Hartsfield, Yudong Tong, Danielle J. Carrier, Shreekar Cheboyina, and Sunil K. Battu. 2008. “Clinical Assessment of CYP2D6-Mediated Herb-Drug Interactions in Humans: Effects of Milk Thistle, Black Cohosh, Goldenseal, Kava Kava, St. John’s Wort, and Echinacea.” Molecular Nutrition & Food Research 52 (7): 755–63. https://doi.org/10.1002/mnfr.200600300.
H.B. NO. 2494 - ‘Awa; Official State Beverage of Hawaii. 2018. https://www.capitol.hawaii.gov/session2018/bills/HB2494_.HTM.
Hannam, Sarah, Michael Murray, Lucia Romani, Meciusela Tuicakau, and Margot J Whitfeld. 2014. “Kava Dermopathy in Fiji: An Acquired Ichthyosis?” International Journal of Dermatology 53 (12): 1490–94. https://doi.org/10.1111/ijd.12546.
Hegazy, Nada Hany, Hans-Georg Breitinger, and Ulrike Breitinger. 2019. “Kavalactones from Kava (Piper Methysticum) Root Extract as Modulators of Recombinant Human Glycine Receptors.” Biological Chemistry 400 (9): 1205–15. https://doi.org/10.1515/hsz-2019-0112.
Heinze, H. J. 1994. “Pharmacopsychological EfTects ofOxazepam and Kava-Extract in a Visual Search Paradigm Assessed with Event-Related Potentials.” Phannacopsychiat. 27: 224–30.
Hocart, C. H., B. Fankhauser, and D. W. Buckle. 1993. “Chemical Archaeology of Kava, a Potent Brew.” Rapid Communications in Mass Spectrometry: RCM 7 (3): 219–24. https://doi.org/10.1002/rcm.1290070311.
Hong, Nguyen Huu, Tran Dang Xuan, Tsuzuki Eiji, Mitsuhiro Matsuo, and Ogushi Yuichi. 2002. “Evaluation of the Allelopathic Potential of Kava (Piper Methysticum L.) for Weed Control in Rice.” Weed Biology and Management 2 (3): 143–47. https://doi.org/10.1046/j.1445-6664.2002.00062.x.
Hoover, Jason M., Alan D. Kaye, Ikhlass N. Ibrahim, Aaron M. Fields, and Todd A. Richards. 2006. “Analysis of Responses to Kava Kava in the Feline Pulmonary Vascular Bed.” Journal of Medicinal Food 9 (1): 62–71. https://doi.org/10.1089/jmf.2006.9.62.
Hussein, Anan. 2015. “A Closer Look at the Risks vs. Benefits of Kava (Piper Methysticum).” Journal of Student Research 4 (2): 69–72. https://doi.org/10.47611/jsr.v4i2.245.
IARC. 2013. “Kava.” In Some Drugs and Herbal Products, 117–40.
“Increasing Consumer Access to Kava.” n.d. Accessed April 19, 2021. https://www.odc.gov.au/publications/increasing-consumer-access-kava.
Jager, L. S. de, G. A. Perfetti, and G. W. Diachenko. 2004. “LC-UV and LC-MS Analysis of Food and Drink Products Containing Kava.” Food Additives and Contaminants 21 (10): 921–34. https://doi.org/10.1080/02652030400010454.
Jaiswal, Yogini S., Aaron M. Yerke, M. Caleb Bagley, Mans Ekelof, Daniel Weber, Daniel Haddad, Anthony Fodor, David C. Muddiman, and Leonard L. Williams. 2020. “3D Imaging and Metabolomic Profiling Reveal Higher Neuroactive Kavalactone Contents in Lateral Roots and Crown Root Peels of Piper Methysticum (kava).” GigaScience 9 (9). https://doi.org/10.5524/100784.
Jaiswal, Yogini, Mohd Farooq Shaikh, Ilya Wang, Yanning Yong, Vanessa Lin Lin Lee, and Leonard Williams. 2020. “Evaluation of Anti-Convulsive Properties of Aqueous Kava Extract on Zebrafish Using the PTZ-Induced Seizure Model.” Brain Sciences 10 (8). https://doi.org/10.3390/brainsci10080541.
Jandial, Danielle D., Lauren S. Krill, Lixia Chen, Chunli Wu, Yu Ke, Jun Xie, Bang H. Hoang, and Xiaolin Zi. 2017. “Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.” Molecules 22 (3). https://doi.org/10.3390/molecules22030462.
Jayararnan, T. K. 2004. “COPING WITH VULNERABILITY BY BUILDING ECONOMIC RESILIENCE: THE CASE OF VANUATU.” In Economic Vulnerability and Resilience of Small States, 135–48. University of Malta. Islands and Small States Institute & The Commonwealth Secretariat.
Jhoo, J-W, J. P. Freeman, C. Y. W. Ang, and J. J. Mihalov. 2006. “Assessment of Kavalactones in Kava Beverage Products and Aqueous Infusions.” Journal of Food Science 71 (6): C345–51. https://doi.org/10.1111/j.1750-3841.2006.00102.x.
Jhoo, Jin-Woo, James P. Freeman, Thomas M. Heinze, Joanna D. Moody, Laura K. Schnackenberg, Richard D. Beger, Klaus Dragull, Chung-Shih Tang, and Catharina Y. W. Ang. 2006. “In Vitro Cytotoxicity of Nonpolar Constituents from Different Parts of Kava Plant (Piper Methysticum).” Journal of Agricultural and Food Chemistry 54 (8): 3157–62. https://doi.org/10.1021/jf051853j.
Johana, A. Mendes, Y. Ekowati Nurhening, S. Susanti Diana, Sembiring Jefri, Prasetia Andri, and Widijastuti Rosmala. 2018. “The Potential Leaves Extract of Piper Methysticum (piperaceae) as Botanical Insecticide against Crocidolomia Pavonana (f.) Larvae Mortality (lepidoptera:crambidae).” E3S Web of Conferences 73: 06015. https://doi.org/10.1051/e3sconf/20187306015.
Johnson, Benjamin M., Sheng-Xiang Qiu, Shide Zhang, Fagen Zhang, Joanna E. Burdette, Linning Yu, Judy L. Bolton, and Richard B. van Breemen. 2003. “Identification of Novel Electrophilic Metabolites of Piper Methysticum Forst (Kava).” Chemical Research in Toxicology 16 (6): 733–40. https://doi.org/10.1021/tx020113r.
Johnson, Thomas E., David Hermanson, Lei Wang, Fekadu Kassie, Pramod Upadhyaya, Michael G. O’Sullivan, Stephen S. Hecht, Junxuan Lu, and Chengguo Xing. 2011. “Lung Tumorigenesis Suppressing Effects of a Commercial Kava Extract and Its Selected Compounds in A/J Mice.” The American Journal of Chinese Medicine 39 (4): 727–42. https://doi.org/10.1142/S0192415X11009202.
Johnson, Thomas E., Fekadu Kassie, M. Gerard O’Sullivan, Mesfin Negia, Timothy E. Hanson, Pramod Upadhyaya, Peter P. Ruvolo, Stephen S. Hecht, and Chengguo Xing. 2008. “Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone plus Benzo[a]pyrene–Induced Lung Tumorigenesis in A/J Mice.” Cancer Prevention Research 1 (6): 430–38. https://doi.org/10.1158/1940-6207.CAPR-08-0027.
Jokhan, Anjeela D., and Patricia A. McLenachan. 2004. “Genetic Fingerprinting of Fijian Kava.” The South Pacific Journal of Natural and Applied Sciences 22 (1): 43–45. https://doi.org/10.1071/sp04008.
Jussofie, A., A. Schmiz, and C. Hiemke. 1994. “Kavapyrone Enriched Extract from Piper Methysticum as Modulator of the GABA Binding Site in Different Regions of Rat Brain.” Psychopharmacology 116 (4): 469–74. https://doi.org/10.1007/BF02247480.
Kandukuru, P., A. S. Huang, J. Dong, H. C. Bittenbender, and Y. Li. 2009. “Rapid Identification of Bacterial Isolates from Aqueous Kava (Piper Methysticum) Extracts by Polymerase Chain Reaction and DNA Sequencing.” Letters in Applied Microbiology 49 (6): 764–68. https://doi.org/10.1111/j.1472-765X.2009.02739.x.
Kautu, Bwarenaba B., Juliana Phillips, Kellie Steele, M. Shawn Mengarelli, and Eric A. Nord. 2017. “A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis Elegans Neuromuscular Transmission.” Journal of Experimental Neuroscience 11 (June): 1179069517705384. https://doi.org/10.1177/1179069517705384.
“Kava.” n.d. Accessed May 5, 2021. https://www.betterhealth.vic.gov.au/health/healthyliving/kava.
Keledjian, J., P. H. Duffield, D. D. Jamieson, R. O. Lidgard, and A. M. Duffield. 1988. “Uptake into Mouse Brain of Four Compounds Present in the Psychoactive Beverage Kava.” Journal of Pharmaceutical Sciences 77 (12): 1003–6. https://doi.org/10.1002/jps.2600771203.
Ketola, Raimo A., Jenni Viinamäki, Ilpo Rasanen, Anna Pelander, and Sirkka Goebeler. 2015. “Fatal Kavalactone Intoxication by Suicidal Intravenous Injection.” Forensic Science International 249 (April): e7–11. https://doi.org/10.1016/j.forsciint.2015.01.032.
Klaus Dragull Jim Henderson Mel C. Jackson Ed Johnston Jerry Konanui G. David Lin Kepā Maly Scot Nelson Jeri Ooka Tom Osborn Helen Rogers Chung-Shih Tang. 2006. Hawaiian ‘Awa Views of an Ethnobotanical Treasure. Edited by Ed Johnston and Helen Rogers. Association for Hawaiian ‘Awa.
Klohs, M. W., Keller, F., Williams, R. E., Toekes, M. I., Cronheim, G. E. 1959. “A Chemical and Pharmacological Investigation of Piper Methysticum Forst.” Journal of Medicinal and Pharmaceutical Chemistry 1 (1): 95–103. https://doi.org/10.1021/jm50002a007.
Kong, Yulong, Xiaoguang Gao, Changyuan Wang, Chenqing Ning, Kexin Liu, Zhihao Liu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, and Qiang Meng. 2018. “Protective Effects of Yangonin from an Edible Botanical Kava against Lithocholic Acid-Induced Cholestasis and Hepatotoxicity.” European Journal of Pharmacology 824 (April): 64–71. https://doi.org/10.1016/j.ejphar.2018.02.002.
Krum, Bárbara Nunes, Catiuscia Molz de Freitas, Ana Paula Chiapinotto Ceretta, Caroline Pilecco Barbosa, Elizete de Moraes Reis, Rahisa Scussel, Emily da Silva Córneo, Ricardo Andrez Machado-de-Ávila, Aline Augusti Boligon, and Roselei Fachinetto. 2021. “Kava Decreases the Stereotyped Behavior Induced by Amphetamine in Mice.” Journal of Ethnopharmacology 265 (January): 113293. https://doi.org/10.1016/j.jep.2020.113293.
Kubátová, A., D. J. Miller, and S. B. Hawthorne. 2001. “Comparison of Subcritical Water and Organic Solvents for Extracting Kava Lactones from Kava Root.” Journal of Chromatography. A 923 (1-2): 187–94. https://doi.org/10.1016/s0021-9673(01)00979-7.
Kuchta, Kenny, Marie Hladikova, Michael Thomsen, Adolf Nahrstedt, and Mathias Schmidt. 2021. “Kava (Piper Methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness.” Drug Research 71 (2): 83–93. https://doi.org/10.1055/a-1268-7135.
Kuchta, Kenny, Pietro de Nicola, and Mathias Schmidt. 2018. “Randomized, Dose-Controlled Double-Blind Trial: Efficacy of an Ethanolic Kava (Piper Methysticum Rhizome) Extract for the Treatment of Anxiety in Elderly Patients: Kava Extract for Anxiety.” Traditional & Kampo Medicine 5 (1): 3–10. https://doi.org/10.1002/tkm2.1079.
Kuchta, Kenny, Mathias Schmidt, and Adolf Nahrstedt. 2015. “German Kava Ban Lifted by Court: The Alleged Hepatotoxicity of Kava (Piper Methysticum) as a Case of Ill-Defined Herbal Drug Identity, Lacking Quality Control, and Misguided Regulatory Politics.” Planta Medica 81 (18): 1647–53. https://doi.org/10.1055/s-0035-1558295.
Kumagai, Momochika, Keisuke Nishikawa, Takashi Mishima, Izumi Yoshida, Masahiro Ide, Akio Watanabe, Kazuhiro Fujita, and Yoshiki Morimoto. 2020. “Fluorinated Kavalactone Inhibited RANKL-Induced Osteoclast Differentiation of RAW264 Cells.” Biological & Pharmaceutical Bulletin 43 (5): 898–903. https://doi.org/10.1248/bpb.b20-00063.
LaPorte, E., J. Sarris, C. Stough, and A. Scholey. 2011. “Neurocognitive Effects of Kava (Piper Methysticum): A Systematic Review.” Human Psychopharmacology 26 (2): 102–11. https://doi.org/10.1002/hup.1180.
Lasme, Privat, Fabrice Davrieux, Didier Montet, and Vincent Lebot. 2008. “Quantification of Kavalactones and Determination of Kava (Piper Methysticum) Chemotypes Using near-Infrared Reflectance Spectroscopy for Quality Control in Vanuatu.” Journal of Agricultural and Food Chemistry 56 (13): 4976–81. https://doi.org/10.1021/jf800439g.
Lebot, V. 1996. “Evidence for Conspecificity of Piper Methysticum Forst. F. and Piper Wichmannii C. DC.” Biochemical Systematics and Ecology. https://doi.org/10.1016/s0305-1978(97)81216-1.
Lebot, V., T. K. T. Do, and L. Legendre. 2014. “Detection of Flavokavins (A, B, C) in Cultivars of Kava (Piper Methysticum) Using High Performance Thin Layer Chromatography (HPTLC).” Food Chemistry 151 (May): 554–60. https://doi.org/10.1016/j.foodchem.2013.11.120.
Lebot, Vincent. 1995. “The Origin And Distribution Of Kava.” Canberra Anthropology 18 (1-2): 20–33. https://doi.org/10.1080/03149099509508407.
Lebot, Vincent, z. Mallikarjuna K. Aradhya, and Richard M. Manshardt. 1991. “Geographic Survey of Genetic Variation in Kava (Piper Methysticum Forst. F. and P. Wichmannii C. DC.).” Pacific Science 45 (2): 169–85. http://hdl.handle.net/10125/518.
Lebot Vincent, Cabalion Pierre. 1988. KAVAS OF VANUATU Cultivars of Piper Methysticum Forst. South Pacific Commission Technical Paper.
Lebot, Vincent, Juliane Kaoh, and Laurent Legendre. 2020. “High-Throughput Analysis of Flavokawains in Kava (Piper Methysticum Forst. F.) Roots, Chips and Powders and Correlations with Their Acetonic Extracts Absorbance.” Food Analytical Methods 13 (8): 1583–93. https://doi.org/10.1007/s12161-020-01781-9.
Lebot, Vincent, and Laurent Legendre. 2016. “Comparison of Kava (Piper Methysticum Forst.) Varieties by UV Absorbance of Acetonic Extracts and High-Performance Thin-Layer Chromatography.” Journal of Food Composition and Analysis: An Official Publication of the United Nations University, International Network of Food Data Systems 48 (May): 25–33. https://doi.org/10.1016/j.jfca.2016.01.009.
Lebot, Vincent, and Joël Levesque. 1996. “Genetic Control of Kavalactone Chemotypes in Piper Methysticum Cultivars.” Phytochemistry 43 (2): 397–403. https://doi.org/10.1016/0031-9422(96)00209-9.
Lebot, Vincent, Dennis J. McKenna, Ed Johnston, Qun Yi Zheng, and Doug McKern. 1999. “Morphological, Phytochemical, and Genetic Variation in Hawaiian Cultivars of ’Awa (Kava,Piper Methysticum, Piperaceae).” Economic Botany 53 (4): 407–18. https://doi.org/10.1007/bf02866720.
Lebot, Vincent, Serge Michalet, and Laurent Legendre. 2019. “Kavalactones and Flavokavins Profiles Contribute to Quality Assessment of Kava (Piper Methysticum G. Forst.), the Traditional Beverage of the Pacific.” Beverages 5 (2): 34. https://doi.org/10.3390/beverages5020034.
Lebot, Vincent, and Patricia Siméoni. 2004. “Is the Quality of Kava (Piper Methysticum Forst. F.) Responsible for Different Geographical Patterns?” Ethnobotany Research and Applications. https://scholarspace.manoa.hawaii.edu/handle/10125/135.
Lehrl, Siegfried. 2004. “Clinical Efficacy of Kava Extract WS 1490 in Sleep Disturbances Associated with Anxiety Disorders. Results of a Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.” Journal of Affective Disorders 78 (2): 101–10. https://doi.org/10.1016/s0165-0327(02)00238-0.
Lemert, E. M. 1967. “Secular Use of Kava in Tonga.” Quarterly Journal of Studies on Alcohol 28 (2): 328–41. https://www.ncbi.nlm.nih.gov/pubmed/6049173.
Lester, R. H. 1941. “Kava Drinking in Vitilevu, Fiji.” Oceania; a Journal Devoted to the Study of the Native Peoples of Australia, New Guinea, and the Islands of the Pacific 12 (2): 97–121. http://www.jstor.org/stable/40327938.
Lhuissier, Tiphaine, Pierre-Edouard Mercier, Serge Michalet, Vincent Lebot, and Laurent Legendre. 2017. “Colorimetric Assessment of Kava (Piper Methysticum Forst.) Quality.” Journal of Food Composition and Analysis: An Official Publication of the United Nations University, International Network of Food Data Systems 59 (June): 27–34. https://doi.org/10.1016/j.jfca.2017.02.005.
Li, Juan, Lei Zheng, Mi Yan, Jing Wu, Yongqing Liu, Xiaona Tian, Wen Jiang, Lu Zhang, and Rongmei Wang. 2020. “Activity and Mechanism of Flavokawain A in Inhibiting P-Glycoprotein Expression in Paclitaxel Resistance of Lung Cancer.” Oncology Letters 19 (1): 379–87. https://doi.org/10.3892/ol.2019.11069.
Li, Xuesen, Zhongbo Liu, Xia Xu, Christopher A. Blair, Zheng Sun, Jun Xie, Michael B. Lilly, and Xiaolin Zi. 2012. “Kava Components down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice.” PloS One 7 (2): e31213. https://doi.org/10.1371/journal.pone.0031213.
Li, Xuesen, Xia Xu, Tao Ji, Zhongbo Liu, Mai Gu, Bang H. Hoang, and Xiaolin Zi. 2014. “Dietary Feeding of Flavokawain A, a Kava Chalcone, Exhibits a Satisfactory Safety Profile and Its Association with Enhancement of Phase II Enzymes in Mice.” Toxicology Reports 1: 2–11. https://doi.org/10.1016/j.toxrep.2014.02.002.
Li, Xuesen, Noriko N. Yokoyama, Saiyang Zhang, Lina Ding, Hong-Min Liu, Michael B. Lilly, Dan Mercola, and Xiaolin Zi. 2015. “Flavokawain A Induces deNEDDylation and Skp2 Degradation Leading to Inhibition of Tumorigenesis and Cancer Progression in the TRAMP Transgenic Mouse Model.” Oncotarget 6 (39): 41809–24. https://doi.org/10.18632/oncotarget.6166.
Li, Yan, Hu Mei, Qiangen Wu, Suhui Zhang, Jia-Long Fang, Leming Shi, and Lei Guo. 2011. “Methysticin and 7,8-Dihydromethysticin Are Two Major Kavalactones in Kava Extract to Induce CYP1A1.” Toxicological Sciences: An Official Journal of the Society of Toxicology 124 (2): 388–99. https://doi.org/10.1093/toxsci/kfr235.
Ligresti, Alessia, Rosaria Villano, Marco Allarà, István Ujváry, and Vincenzo Di Marzo. 2012. “Kavalactones and the Endocannabinoid System: The Plant-Derived Yangonin Is a Novel CB₁ Receptor Ligand.” Pharmacological Research: The Official Journal of the Italian Pharmacological Society 66 (2): 163–69. https://doi.org/10.1016/j.phrs.2012.04.003.
Lim, Steven T. S., Klaus Dragull, Chung-Shih Tang, Harry C. Bittenbender, Jimmy T. Efird, and Pratibha V. Nerurkar. 2007. “Effects of Kava Alkaloid, Pipermethystine, and Kavalactones on Oxidative Stress and Cytochrome P450 in F-344 Rats.” Toxicological Sciences: An Official Journal of the Society of Toxicology 97 (1): 214–21. https://doi.org/10.1093/toxsci/kfm035.
Lin, Chien-Tsong, K. Jayabal Senthil Kumar, Yen-Hsueh Tseng, Zi-Jie Wang, Mu-Yun Pan, Jun-Hong Xiao, Shih-Chang Chien, and Sheng-Yang Wang. 2009. “Anti-Inflammatory Activity of Flavokawain B from Alpinia Pricei Hayata.” Journal of Agricultural and Food Chemistry 57 (14): 6060–65. https://doi.org/10.1021/jf900517d.
Lindstrom, Lamont. 2009. “Kava Pirates in Vanuatu?” International Journal of Cultural Property 16 (03): 291–308. https://doi.org/10.1017/S0940739109990208.
Liu, Ying, Jensen A. Lund, Susan J. Murch, and Paula N. Brown. 2018. “Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper Methysticum (Kava).” Planta Medica 84 (16): 1213–18. https://doi.org/10.1055/a-0637-2400.
Last edited: